CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: (S)-thalidomide
Accession: CHEBI:61918
browse the term
Definition: A 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione that has S-configuration at the chiral centre.
Synonyms: exact_synonym: 2-[(3S)-2,6-dioxopiperidin-3-yl]-1H-isoindole-1,3(2H)-dione
related_synonym: (-)-thalidomide; Formula=C13H10N2O4; InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)/t9-/m0/s1; InChIKey=UEJJHQNACJXSKW-VIFPVBQESA-N; L-thalidomide; SMILES=O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1
xref: CAS:841-67-8; Reaxys:5756816
cyclic_relationship: is_enantiomer_of CHEBI:61917
G
Brd4
bromodomain containing 4
multiple interactions
ISO
pomalidomide inhibits the reaction [ARV-825 results in increased degradation of BRD4 protein]
CTD
PMID:26051217
NCBI chr 7:14,222,101...14,303,055
Ensembl chr 7:14,222,101...14,303,055
G
Casp3
caspase 3
multiple interactions
ISO
[afuresertib co-treated with pomalidomide co-treated with Dexamethasone] results in increased cleavage of CASP3 protein
CTD
PMID:29928335
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Casp8
caspase 8
multiple interactions
ISO
[afuresertib co-treated with pomalidomide co-treated with Dexamethasone] results in increased cleavage of CASP8 protein
CTD
PMID:29928335
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
G
Ccl2
C-C motif chemokine ligand 2
increases secretion
ISO
pomalidomide results in increased secretion of CCL2 protein
CTD
PMID:15292067
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
G
Cebpa
CCAAT/enhancer binding protein alpha
increases expression
ISO
pomalidomide results in increased expression of CEBPA mRNA
CTD
PMID:15292067
NCBI chr 1:91,363,492...91,366,164
Ensembl chr 1:91,363,492...91,366,164
G
Cebpd
CCAAT/enhancer binding protein delta
increases expression
ISO
pomalidomide results in increased expression of CEBPD mRNA
CTD
PMID:15292067
NCBI chr11:89,008,008...89,009,146
Ensembl chr11:89,008,008...89,009,146
G
Cebpe
CCAAT/enhancer binding protein epsilon
increases expression
ISO
pomalidomide results in increased expression of CEBPE mRNA
CTD
PMID:15292067
NCBI chr15:33,356,119...33,357,517
Ensembl chr15:33,355,947...33,358,138
G
Crbn
cereblon
multiple interactions affects binding increases response to substance
ISO
[pomalidomide co-treated with Dexamethasone co-treated with afuresertib] results in increased expression of CRBN protein; [pomalidomide co-treated with Dexamethasone] results in increased expression of CRBN protein; pomalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein] pomalidomide binds to [SALL4 protein binds to CRBN protein] CRBN results in increased susceptibility to pomalidomide
CTD
PMID:25043012 PMID:26186254 PMID:29928335 PMID:30067223
NCBI chr 4:138,864,910...138,885,786
Ensembl chr 4:138,866,761...138,885,556
G
Csf2
colony stimulating factor 2
decreases secretion
ISO
pomalidomide results in decreased secretion of CSF2 protein
CTD
PMID:15292067
NCBI chr10:39,602,089...39,604,070
Ensembl chr10:39,602,089...39,604,070
G
Csf3
colony stimulating factor 3
increases secretion
ISO
pomalidomide results in increased secretion of CSF3 protein
CTD
PMID:15292067
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
G
Cyp2c6v1
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1
increases oxidation
ISO
CYP2C19 protein results in increased oxidation of pomalidomide
CTD
PMID:24350712
NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
increases oxidation
ISO
CYP2J2 protein results in increased oxidation of pomalidomide
CTD
PMID:24350712
NCBI chr 5:119,546,458...119,564,843
Ensembl chr 5:119,546,461...119,564,846
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
increases oxidation
ISO
CYP3A4 protein results in increased oxidation of pomalidomide
CTD
PMID:24350712
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
G
Dtwd1
DTW domain containing 1
multiple interactions
ISO
pomalidomide results in increased degradation of and results in decreased expression of DTWD1 protein
CTD
PMID:30067223
NCBI chr 3:118,427,790...118,443,003
Ensembl chr 3:118,430,511...118,442,098
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
multiple interactions
ISO
[pomalidomide co-treated with Dexamethasone] results in decreased phosphorylation of EIF4EBP1 protein; afuresertib promotes the reaction [[pomalidomide co-treated with Dexamethasone] results in decreased phosphorylation of EIF4EBP1 protein]
CTD
PMID:29928335
NCBI chr16:68,954,860...68,968,248
Ensembl chr16:68,954,875...68,968,248
G
Fam83f
family with sequence similarity 83, member F
multiple interactions
ISO
pomalidomide results in increased degradation of and results in decreased expression of FAM83F protein
CTD
PMID:30067223
NCBI chr 7:121,889,157...121,918,772
Ensembl chr 7:121,889,157...121,918,772
G
Fgfr1
Fibroblast growth factor receptor 1
decreases expression
ISO
pomalidomide results in decreased expression of FGFR1 mRNA
CTD
PMID:30834740
NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
G
Fgfr3
fibroblast growth factor receptor 3
affects expression
ISO
pomalidomide affects the expression of FGFR3 mRNA
CTD
PMID:30834740
NCBI chr14:82,272,322...82,287,739
Ensembl chr14:82,273,070...82,287,706
G
Foxo1
forkhead box O1
multiple interactions
ISO
[pomalidomide co-treated with Dexamethasone] affects the phosphorylation of FOXO1 protein; afuresertib affects the reaction [[pomalidomide co-treated with Dexamethasone] affects the phosphorylation of FOXO1 protein]
CTD
PMID:29928335
NCBI chr 2:141,451,234...141,527,016
Ensembl chr 2:141,451,234...141,527,016
G
Gata1
GATA binding protein 1
decreases expression
ISO
pomalidomide results in decreased expression of GATA1 mRNA; pomalidomide results in decreased expression of GATA1 protein
CTD
PMID:15292067
NCBI chr X:15,273,937...15,281,759
Ensembl chr X:15,378,789...15,382,066
G
Gata2
GATA binding protein 2
decreases expression
ISO
pomalidomide results in decreased expression of GATA2 mRNA
CTD
PMID:15292067
NCBI chr 4:120,129,028...120,142,490
Ensembl chr 4:120,133,713...120,142,488
G
Gfi1
growth factor independent 1 transcriptional repressor
increases expression
ISO
pomalidomide results in increased expression of GFI1 mRNA
CTD
PMID:15292067
NCBI chr14:3,058,035...3,073,332
Ensembl chr14:3,058,993...3,068,371
G
Gfi1b
growth factor independent 1B transcriptional repressor
decreases expression
ISO
pomalidomide results in decreased expression of GFI1B mRNA
CTD
PMID:15292067
NCBI chr 3:7,190,721...7,203,444
Ensembl chr 3:7,190,722...7,203,420
G
Id1
inhibitor of DNA binding 1, HLH protein
increases expression
ISO
pomalidomide results in increased expression of ID1 mRNA
CTD
PMID:15292067
NCBI chr 3:148,214,623...148,216,715
Ensembl chr 3:148,215,540...148,216,718
G
Id2
inhibitor of DNA binding 2
increases expression
ISO
pomalidomide results in increased expression of ID2 mRNA
CTD
PMID:15292067
NCBI chr 6:44,360,077...44,361,908
Ensembl chr 6:44,348,501...44,363,915
G
Ikzf1
IKAROS family zinc finger 1
multiple interactions
ISO
[pomalidomide co-treated with Dexamethasone] results in decreased expression of IKZF1 protein; afuresertib promotes the reaction [[pomalidomide co-treated with Dexamethasone] results in decreased expression of IKZF1 protein]
CTD
PMID:29928335
NCBI chr14:91,782,281...91,867,828
Ensembl chr14:91,782,354...91,867,424
G
Ikzf3
IKAROS family zinc finger 3
multiple interactions
ISO
[pomalidomide co-treated with Dexamethasone] results in decreased expression of IKZF3 protein; afuresertib promotes the reaction [[pomalidomide co-treated with Dexamethasone] results in decreased expression of IKZF3 protein]
CTD
PMID:29928335
NCBI chr10:86,420,757...86,509,454
Ensembl chr10:86,421,582...86,509,454
G
Il10
interleukin 10
increases secretion
ISO
pomalidomide results in increased secretion of IL10 protein
CTD
PMID:15292067
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Il13
interleukin 13
decreases secretion
ISO
pomalidomide results in decreased secretion of IL13 protein
CTD
PMID:15292067
NCBI chr10:38,982,909...38,985,466
Ensembl chr10:38,982,909...38,985,466
G
Il2
interleukin 2
multiple interactions
ISO
Go 6976 inhibits the reaction [pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]]; pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA]; pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]; pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IL2 protein]; rottlerin inhibits the reaction [pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]]
CTD
PMID:16241859
NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
G
Il5
interleukin 5
decreases secretion
ISO
pomalidomide results in decreased secretion of IL5 protein
CTD
PMID:15292067
NCBI chr10:39,066,716...39,069,587
Ensembl chr10:39,066,716...39,069,587
G
Irf4
interferon regulatory factor 4
multiple interactions
ISO
[pomalidomide co-treated with Dexamethasone co-treated with afuresertib] results in decreased expression of IRF4 protein; [pomalidomide co-treated with Dexamethasone] results in decreased expression of IRF4 protein
CTD
PMID:29928335
NCBI chr17:34,886,746...34,905,191
Ensembl chr17:34,886,739...34,905,117
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
pomalidomide results in decreased expression of JUND mRNA
CTD
PMID:15292067
NCBI chr16:20,485,028...20,486,707
Ensembl chr16:20,485,029...20,486,707
G
Klf1
Kruppel like factor 1
decreases expression
ISO
pomalidomide results in decreased expression of KLF1 mRNA
CTD
PMID:15292067
NCBI chr19:26,016,289...26,019,557
Ensembl chr19:26,016,382...26,019,553
G
Lmo2
LIM domain only 2
decreases expression
ISO
pomalidomide results in decreased expression of LMO2 mRNA
CTD
PMID:15292067
NCBI chr 3:93,909,156...93,931,888
Ensembl chr 3:93,909,156...93,931,871
G
Meis2
Meis homeobox 2
multiple interactions
ISO
pomalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein]
CTD
PMID:25043012
NCBI chr 3:107,560,172...107,762,732
Ensembl chr 3:107,559,997...107,760,589
G
Nfe2
nuclear factor, erythroid 2
decreases expression
ISO
pomalidomide results in decreased expression of NFE2 mRNA
CTD
PMID:15292067
NCBI chr 7:144,872,739...144,880,092
Ensembl chr 7:144,872,747...144,880,092
G
Prkcq
protein kinase C, theta
multiple interactions
ISO
pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of PRKCQ protein]
CTD
PMID:16241859
NCBI chr17:70,971,915...71,105,286
Ensembl chr17:70,971,915...71,105,286
G
Rab28
RAB28, member RAS oncogene family
multiple interactions
ISO
pomalidomide results in increased degradation of and results in decreased expression of RAB28 protein
CTD
PMID:30067223
NCBI chr14:73,888,968...73,963,209
Ensembl chr14:73,889,213...73,963,202
G
Sall4
spalt-like transcription factor 4
affects binding multiple interactions
ISO
pomalidomide binds to [SALL4 protein binds to CRBN protein] pomalidomide results in increased degradation of and results in decreased expression of SALL4 protein
CTD
PMID:30067223
NCBI chr 3:165,520,155...165,538,176
Ensembl chr 3:165,520,392...165,537,940
G
Spi1
Spi-1 proto-oncogene
increases expression decreases expression
ISO
pomalidomide results in increased expression of SPI1 mRNA pomalidomide results in decreased expression of SPI1 protein
CTD
PMID:15292067 PMID:16373662
NCBI chr 3:79,918,127...79,937,708
Ensembl chr 3:79,918,969...79,938,301
G
Wiz
WIZ zinc finger
multiple interactions
ISO
pomalidomide results in increased degradation of and results in decreased expression of WIZ protein
CTD
PMID:30067223
NCBI chr 7:14,374,358...14,402,647
Ensembl chr 7:14,374,358...14,402,010
G
Zbtb39
zinc finger and BTB domain containing 39
multiple interactions
ISO
pomalidomide results in increased degradation of and results in decreased expression of ZBTB39 protein
CTD
PMID:30067223
NCBI chr 7:71,036,581...71,044,057
Ensembl chr 7:71,036,565...71,044,045
G
Zfp653
zinc finger protein 653
multiple interactions
ISO
pomalidomide results in increased degradation of and results in decreased expression of ZNF653 protein
CTD
PMID:30067223
NCBI chr 8:23,066,576...23,085,502
Ensembl chr 8:23,066,576...23,084,879
G
Zfp91
zinc finger protein 91
multiple interactions
ISO
pomalidomide results in increased degradation of and results in decreased expression of ZFP91 protein
CTD
PMID:30067223
NCBI chr 1:229,602,499...229,640,906
Ensembl chr 1:229,602,499...229,639,187
G
Aadat
aminoadipate aminotransferase
decreases expression
ISO
Thalidomide results in decreased expression of AADAT mRNA
CTD
PMID:26217789
NCBI chr16:32,832,001...32,868,680
Ensembl chr16:32,832,061...32,868,702
G
Abca1
ATP binding cassette subfamily A member 1
increases response to substance
ISO
ABCA1 gene SNP results in increased susceptibility to Thalidomide
CTD
PMID:21245421
NCBI chr 5:69,857,717...69,983,042
Ensembl chr 5:69,857,771...69,983,015
G
Abcb1a
ATP binding cassette subfamily B member 1A
decreases expression decreases activity
ISO
Thalidomide results in decreased expression of ABCB1 mRNA; Thalidomide results in decreased expression of ABCB1 protein Thalidomide results in decreased activity of ABCB1 protein
CTD
PMID:15920492 PMID:19840843
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
G
Abcb1b
ATP-binding cassette, subfamily B (MDR/TAP), member 1B
increases expression increases activity
EXP
Thalidomide results in increased expression of ABCB1B protein Thalidomide results in increased activity of ABCB1B protein
CTD
PMID:19840843
NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
G
Acp5
acid phosphatase 5, tartrate resistant
multiple interactions
ISO
[Thalidomide co-treated with Dexamethasone] results in decreased expression of ACP5 protein
CTD
PMID:16079895
NCBI chr 8:23,142,733...23,149,067
Ensembl chr 8:23,142,734...23,148,396
G
Acta2
actin alpha 2, smooth muscle
multiple interactions decreases expression
EXP
[Thalidomide co-treated with Dimethylnitrosamine] results in decreased expression of ACTA2 protein; Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]; Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 mRNA]; Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 protein]; Thalidomide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] Thalidomide results in decreased expression of ACTA2 protein
CTD
PMID:16604421 PMID:16943688 PMID:17030452 PMID:17174718
NCBI chr 1:252,537,614...252,550,394
Ensembl chr 1:252,537,615...252,550,394
G
Actn2
actinin alpha 2
decreases expression
ISO
Thalidomide results in decreased expression of ACTN2 mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr17:66,304,530...66,397,647
Ensembl chr17:66,304,501...66,397,653
G
Actr6
actin related protein 6
decreases expression
ISO
Thalidomide results in decreased expression of ACTR6 mRNA
CTD
PMID:26217789
NCBI chr 7:30,377,369...30,397,922
Ensembl chr 7:30,377,360...30,397,930
G
Adssl1
adenylosuccinate synthase like 1
decreases expression
ISO
Thalidomide results in decreased expression of ADSSL1 mRNA
CTD
PMID:26217789
NCBI chr 6:137,184,818...137,206,694
Ensembl chr 6:137,184,820...137,206,693
G
Aff2
AF4/FMR2 family, member 2
decreases expression
ISO
Thalidomide results in decreased expression of AFF2 mRNA
CTD
PMID:26217789
NCBI chr X:153,539,951...154,051,022
Ensembl chr X:153,539,668...154,051,181
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation decreases activity increases phosphorylation
ISO
Thalidomide analog results in decreased phosphorylation of AKT1 protein Thalidomide results in decreased activity of AKT1 protein Thalidomide analog results in increased phosphorylation of AKT1 protein
CTD
PMID:15067094 PMID:15858615
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
decreases expression
ISO
Thalidomide results in decreased expression of ALDH1A2 mRNA
CTD
PMID:31711903
NCBI chr 8:77,640,234...77,719,488
Ensembl chr 8:77,640,222...77,719,489
G
Alpi
alkaline phosphatase, intestinal
increases expression
ISO
Thalidomide results in increased expression of ALPI mRNA
CTD
PMID:26217789
NCBI chr 9:94,197,616...94,201,910
Ensembl chr 9:94,197,618...94,201,084
G
Amacr
alpha-methylacyl-CoA racemase
decreases expression
ISO
Thalidomide results in decreased expression of AMACR mRNA
CTD
PMID:26217789
NCBI chr 2:60,949,276...60,961,342
Ensembl chr 2:60,949,256...60,961,326
G
Angpt2
angiopoietin 2
affects expression
ISO
Thalidomide affects the expression of ANGPT2 mRNA
CTD
PMID:15939924
NCBI chr16:75,966,480...76,016,147
Ensembl chr16:75,966,352...76,016,195
G
Ankrd37
ankyrin repeat domain 37
decreases expression
ISO
Thalidomide results in decreased expression of ANKRD37 mRNA
CTD
PMID:26217789
NCBI chr16:49,463,016...49,465,905
Ensembl chr16:49,462,889...49,465,888
G
Anxa2
annexin A2
decreases expression
ISO
Thalidomide results in decreased expression of ANXA2 mRNA; Thalidomide results in decreased expression of ANXA2 protein
CTD
PMID:19954599
NCBI chr 8:75,687,134...75,723,589
Ensembl chr 8:75,687,100...75,723,594
G
Apip
APAF1 interacting protein
decreases expression
ISO
Thalidomide results in decreased expression of APIP mRNA
CTD
PMID:26217789
NCBI chr 3:92,969,128...92,998,104
Ensembl chr 3:92,969,141...92,995,483
G
Apln
apelin
decreases expression
ISO
Thalidomide results in decreased expression of APLN mRNA
CTD
PMID:26217789
NCBI chr X:134,856,719...134,866,210
Ensembl chr X:134,856,726...134,866,210
G
Aqp4
aquaporin 4
increases expression
ISO
Thalidomide results in increased expression of AQP4 mRNA
CTD
PMID:26217789
NCBI chr18:6,766,009...6,782,757
Ensembl chr18:6,765,945...6,782,996
G
Aqp5
aquaporin 5
increases expression
ISO
Thalidomide results in increased expression of AQP5 mRNA
CTD
PMID:26217789
NCBI chr 7:141,249,044...141,252,576
Ensembl chr 7:141,249,044...141,252,578
G
Arhgdia
Rho GDP dissociation inhibitor alpha
increases expression
ISO
Thalidomide results in increased expression of ARHGDIA mRNA
CTD
PMID:26217789
NCBI chr10:109,754,012...109,757,506
Ensembl chr10:109,754,004...109,757,550
G
Arpc4
actin related protein 2/3 complex, subunit 4
decreases expression
ISO
Thalidomide results in decreased expression of ARPC4 mRNA
CTD
PMID:26217789
NCBI chr 4:145,330,457...145,340,985
Ensembl chr 4:145,330,457...145,340,984
G
Arx
aristaless related homeobox
increases expression
ISO
Thalidomide results in increased expression of ARX mRNA
CTD
PMID:26217789
NCBI chr X:62,363,757...62,376,139
Ensembl chr X:62,363,757...62,376,143
G
Asb12
ankyrin repeat and SOCS box-containing 12
decreases expression
ISO
Thalidomide results in decreased expression of ASB12 mRNA
CTD
PMID:26217789
NCBI chr X:64,714,337...64,800,662
Ensembl chr X:64,714,335...64,800,435
G
Atf3
activating transcription factor 3
increases expression
ISO
Thalidomide analog results in increased expression of ATF3 mRNA
CTD
PMID:20525221
NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
G
Aurka
aurora kinase A
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of AURKA mRNA
CTD
PMID:18720364
NCBI chr 3:170,364,177...170,380,278
Ensembl chr 3:170,364,181...170,378,210
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
EXP
Thalidomide results in increased expression of BAX mRNA
CTD
PMID:18291259
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Bcap29
B-cell receptor-associated protein 29
decreases expression
ISO
Thalidomide results in decreased expression of BCAP29 mRNA
CTD
PMID:26217789
NCBI chr 6:50,883,758...50,923,743
Ensembl chr 6:50,883,787...50,923,510
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression
ISO
[oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 mRNA; [oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 protein Thalidomide results in decreased expression of BCL2 protein
CTD
PMID:15867202 PMID:15982930
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
Thalidomide results in decreased expression of BCL2L1 protein
CTD
PMID:15986355
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
G
Bdkrb1
bradykinin receptor B1
multiple interactions
ISO
Thalidomide inhibits the reaction [bradykinin, des-Arg(9)- results in increased expression of BDKRB1 protein]
CTD
PMID:16039549
NCBI chr 6:129,437,423...129,441,553
Ensembl chr 6:129,438,158...129,440,574
G
Becn1
beclin 1
multiple interactions
ISO
Thalidomide promotes the reaction [temozolomide results in increased expression of BECN1 protein]
CTD
PMID:19567134
NCBI chr10:89,209,944...89,225,297
Ensembl chr10:89,209,940...89,225,297
G
Bnipl
BCL2 interacting protein like
increases expression
ISO
Thalidomide results in increased expression of BNIPL mRNA
CTD
PMID:26217789
NCBI chr 2:196,415,736...196,425,727
Ensembl chr 2:196,415,738...196,425,727
G
Bod1
biorientation of chromosomes in cell division 1
decreases expression
ISO
Thalidomide results in decreased expression of BOD1 mRNA
CTD
PMID:26217789
NCBI chr10:16,259,728...16,266,069
Ensembl chr10:16,259,728...16,266,061
G
Bst2
bone marrow stromal cell antigen 2
decreases expression
ISO
Thalidomide results in decreased expression of BST2 mRNA
CTD
PMID:26217789
NCBI chr16:19,938,781...19,942,353
Ensembl chr16:19,938,784...19,942,353
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of BUB1B mRNA
CTD
PMID:18720364
NCBI chr 3:110,367,949...110,420,471
Ensembl chr 3:110,367,939...110,420,458
G
C3
complement C3
decreases expression
ISO
Thalidomide results in decreased expression of C3 protein
CTD
PMID:2985516
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
G
Cacna1c
calcium voltage-gated channel subunit alpha1 C
decreases expression
ISO
Thalidomide results in decreased expression of CACNA1C mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr 4:150,635,808...151,270,790
Ensembl chr 4:150,641,066...150,829,913
G
Calb1
calbindin 1
decreases expression
ISO
Thalidomide results in decreased expression of CALB1 mRNA
CTD
PMID:24154490
NCBI chr 5:29,538,380...29,562,774
Ensembl chr 5:29,538,380...29,562,773
G
Casp3
caspase 3
decreases activity increases expression increases activity
ISO EXP
Thalidomide results in decreased activity of CASP3 protein Thalidomide results in increased expression of CASP3 mRNA Thalidomide results in increased activity of CASP3 protein
CTD
PMID:14682394 PMID:15067094 PMID:18291259
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Casp8
caspase 8
increases cleavage decreases expression
ISO
Thalidomide analog results in increased cleavage of CASP8 protein Thalidomide results in decreased expression of CASP8 mRNA
CTD
PMID:15858615 PMID:26217789
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
G
Casp9
caspase 9
decreases activity
ISO
Thalidomide results in decreased activity of CASP9 protein
CTD
PMID:15067094
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
G
Castor1
cytosolic arginine sensor for mTORC1 subunit 1
decreases expression
ISO
Thalidomide results in decreased expression of CASTOR1 mRNA
CTD
PMID:26217789
NCBI chr14:84,447,552...84,457,396
Ensembl chr14:84,447,885...84,452,367
G
Cat
catalase
multiple interactions
ISO
CAT protein inhibits the reaction [Thalidomide results in decreased activity of MYB protein]
CTD
PMID:16616857
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
G
Cbr1
carbonyl reductase 1
decreases expression
ISO
Thalidomide results in decreased expression of CBR1 mRNA
CTD
PMID:26217789
NCBI chr11:33,813,041...33,815,418
Ensembl chr11:33,845,463...33,847,793
G
Ccdc130
coiled-coil domain containing 130
decreases expression
ISO
Thalidomide results in decreased expression of CCDC130 mRNA
CTD
PMID:26217789
NCBI chr19:25,367,552...25,378,993
Ensembl chr19:25,367,543...25,378,974
G
Ccdc141
coiled-coil domain containing 141
decreases expression
ISO
Thalidomide results in decreased expression of CCDC141 mRNA
CTD
PMID:26217789
NCBI chr 3:63,865,240...64,024,208
Ensembl chr 3:63,863,951...64,024,205
G
Ccl2
C-C motif chemokine ligand 2
decreases expression
ISO
Thalidomide analog results in decreased expression of CCL2 mRNA
CTD
PMID:20525221
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
G
Ccl3
C-C motif chemokine ligand 3
increases expression
EXP
Thalidomide results in increased expression of CCL3 mRNA
CTD
PMID:16549389
NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066
G
Ccna2
cyclin A2
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of CCNA2 mRNA
CTD
PMID:18720364
NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214
G
Ccnb1
cyclin B1
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of CCNB1 mRNA
CTD
PMID:18720364
NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
G
Ccnd1
cyclin D1
decreases expression
ISO
Thalidomide analog results in decreased expression of CCND1 mRNA
CTD
PMID:20525221
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
G
Ccno
cyclin O
increases expression
ISO
Thalidomide results in increased expression of CCNO mRNA
CTD
PMID:26217789
NCBI chr 2:44,857,043...44,860,317
Ensembl chr 2:44,857,213...44,860,315
G
Cd24
CD24 molecule
affects expression
ISO
Thalidomide affects the expression of CD24A mRNA
CTD
PMID:26006729
NCBI chr20:48,335,540...48,340,847
Ensembl chr20:48,335,540...48,340,846
G
Cdc20
cell division cycle 20
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of CDC20 mRNA
CTD
PMID:18720364
NCBI chr 5:137,260,728...137,264,931
Ensembl chr 5:137,260,739...137,265,015
G
Cdc42ep5
CDC42 effector protein 5
decreases expression
ISO
Thalidomide results in decreased expression of CDC42EP5 mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr 1:73,717,207...73,719,600
Ensembl chr 1:73,719,005...73,719,529
G
Cdh10
cadherin 10
decreases expression
ISO
Thalidomide results in decreased expression of CDH10 mRNA
CTD
PMID:26217789
NCBI chr 2:69,415,174...69,636,849
Ensembl chr 2:69,415,057...69,637,524
G
Cdk1
cyclin-dependent kinase 1
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of CDK1 mRNA
CTD
PMID:18720364
NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
G
Cenpa
centromere protein A
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of CENPA mRNA
CTD
PMID:18720364
NCBI chr 6:27,072,259...27,080,863
Ensembl chr 6:27,072,166...27,080,856
G
Cenpf
centromere protein F
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of CENPF mRNA
CTD
PMID:18720364
NCBI chr13:108,132,499...108,178,609
Ensembl chr13:108,132,499...108,178,609
G
Cer1
cerberus 1, DAN family BMP antagonist
decreases expression
ISO
Thalidomide results in decreased expression of CER1 mRNA
CTD
PMID:26217789
NCBI chr 5:101,003,019...101,006,375
Ensembl chr 5:101,003,023...101,006,375
G
Cfc1
cripto, FRL-1, cryptic family 1
decreases expression
ISO
Thalidomide results in decreased expression of CFC1 mRNA
CTD
PMID:26217789
NCBI chr 9:41,045,352...41,051,979
Ensembl chr 9:41,045,363...41,052,024
G
Cflar
CASP8 and FADD-like apoptosis regulator
decreases expression
ISO
Thalidomide results in decreased expression of CFLAR protein
CTD
PMID:15986355
NCBI chr 9:65,534,608...65,586,395
Ensembl chr 9:65,534,704...65,587,251
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
multiple interactions
EXP
Thalidomide inhibits the reaction [TNF protein results in increased expression of CHUK protein]
CTD
PMID:16604421
NCBI chr 1:263,848,829...263,884,354
Ensembl chr 1:263,848,884...263,885,169
G
Churc1
churchill domain containing 1
decreases expression
ISO
Thalidomide results in decreased expression of CHURC1 mRNA
CTD
PMID:26217789
NCBI chr 6:99,817,439...99,831,574
Ensembl chr 6:99,817,431...99,831,576
G
Cldn4
claudin 4
increases expression
ISO
Thalidomide results in increased expression of CLDN4 mRNA
CTD
PMID:26217789
NCBI chr12:24,761,210...24,763,008
Ensembl chr12:24,761,210...24,763,005
G
Cldnd1
claudin domain containing 1
decreases expression
ISO
Thalidomide results in decreased expression of CLDND1 mRNA
CTD
PMID:26217789
NCBI chr11:43,986,352...43,992,703
Ensembl chr11:43,986,386...43,992,598
G
Clec9a
C-type lectin domain containing 9A
decreases expression
ISO
Thalidomide results in decreased expression of CLEC9A mRNA
CTD
PMID:26217789
NCBI chr 4:163,173,593...163,189,532
Ensembl chr 4:163,174,487...163,189,530
G
Col1a1
collagen type I alpha 1 chain
multiple interactions
EXP
Thalidomide inhibits the reaction [Paraquat results in increased expression of COL1A1 mRNA]; Thalidomide inhibits the reaction [Paraquat results in increased expression of COL1A1 protein]
CTD
PMID:26221080
NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
G
Col1a2
collagen type I alpha 2 chain
multiple interactions
EXP
Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of COL1A2 mRNA]; Thalidomide inhibits the reaction [TNF protein results in increased expression of COL1A2 mRNA]
CTD
PMID:16604421
NCBI chr 4:31,534,225...31,569,152
Ensembl chr 4:31,534,225...31,569,151
G
Crbn
cereblon
multiple interactions affects binding affects response to substance
ISO
Thalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein] Thalidomide binds to [CRBN protein binds to DDB1 protein] CRBN gene SNP affects the susceptibility to Thalidomide Thalidomide binds to [SALL4 protein binds to CRBN protein]; Thalidomide binds to CRBN protein
CTD
PMID:25043012 PMID:25108355 PMID:27751757 PMID:30067223
NCBI chr 4:138,864,910...138,885,786
Ensembl chr 4:138,866,761...138,885,556
G
Crebrf
CREB3 regulatory factor
increases expression
ISO
Thalidomide analog results in increased expression of CREBRF mRNA
CTD
PMID:20525221
NCBI chr10:16,693,846...16,753,162
Ensembl chr10:16,694,792...16,752,205
G
Crp
C-reactive protein
decreases expression
ISO
Thalidomide results in decreased expression of CRP protein
CTD
PMID:11339241
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
G
Csf2
colony stimulating factor 2
decreases activity
ISO
Thalidomide results in decreased activity of CSF2 protein
CTD
PMID:17557286
NCBI chr10:39,602,089...39,604,070
Ensembl chr10:39,602,089...39,604,070
G
Csf3
colony stimulating factor 3
decreases activity
ISO
Thalidomide results in decreased activity of CSF3 protein
CTD
PMID:17557286
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
G
Csgalnact2
chondroitin sulfate N-acetylgalactosaminyltransferase 2
decreases expression
ISO
Thalidomide results in decreased expression of CSGALNACT2 mRNA
CTD
PMID:26217789
NCBI chr 4:150,148,626...150,185,062
Ensembl chr 4:150,153,844...150,185,044
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
ISO
Thalidomide results in increased expression of CXCL10
CTD
PMID:17089043
NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
G
Cxcr1
C-X-C motif chemokine receptor 1
decreases expression
ISO
Thalidomide results in decreased expression of CXCR1 protein
CTD
PMID:16344495
NCBI chr 9:81,466,430...81,469,299
Ensembl chr 9:81,466,332...81,469,274
G
Cxcr2
C-X-C motif chemokine receptor 2
decreases expression
ISO
Thalidomide results in decreased expression of CXCR2 protein
CTD
PMID:16344495
NCBI chr 9:81,427,275...81,435,065
Ensembl chr 9:81,427,730...81,434,102
G
Cycs
cytochrome c, somatic
increases expression
ISO
Thalidomide results in increased expression of CYCS protein
CTD
PMID:15982930
NCBI chr 4:80,331,226...80,333,326
Ensembl chr 4:80,331,227...80,333,326
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
increases expression
ISO
Thalidomide results in increased expression of CYP2B6 mRNA
CTD
PMID:24460184 PMID:28496040
NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
G
Cyp2c6v1
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1
increases hydroxylation multiple interactions increases oxidation
ISO
CYP2C19 protein results in increased hydroxylation of Thalidomide [CYP2C19 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5'-hydroxythalidomide; [CYP2C19 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5-hydroxythalidomide; [CYP2C19 protein results in increased oxidation of Thalidomide] which results in increased abundance of 5'-hydroxythalidomide; [CYP2C19 protein results in increased oxidation of Thalidomide] which results in increased abundance of 5-hydroxythalidomide
CTD
PMID:20443640 PMID:24350712
NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
increases expression increases hydroxylation multiple interactions increases metabolic processing
ISO
Thalidomide results in increased expression of CYP3A4 mRNA; Thalidomide results in increased expression of CYP3A4 protein CYP3A4 protein results in increased hydroxylation of Thalidomide [CYP3A4 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5-hydroxythalidomide CYP3A4 protein results in increased metabolism of Thalidomide
CTD
PMID:20443640 PMID:24460184 PMID:28496040 PMID:28745489
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
multiple interactions increases metabolic processing increases expression increases hydroxylation
ISO
[CYP3A5 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5-hydroxythalidomide CYP3A5 protein results in increased metabolism of Thalidomide Thalidomide results in increased expression of CYP3A5 mRNA
CTD
PMID:20443640 PMID:28496040 PMID:28745489
NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
G
Cyth3
cytohesin 3
decreases expression
ISO
Thalidomide results in decreased expression of CYTH3 mRNA
CTD
PMID:26217789
NCBI chr12:12,877,559...12,907,771
Ensembl chr12:12,877,559...12,945,192
G
Daam2
dishevelled associated activator of morphogenesis 2
decreases expression
ISO
Thalidomide results in decreased expression of DAAM2 mRNA
CTD
PMID:26217789
NCBI chr 9:13,444,883...13,493,154
Ensembl chr 9:13,446,896...13,490,669
G
Dbt
dihydrolipoamide branched chain transacylase E2
decreases expression
ISO
Thalidomide results in decreased expression of DBT mRNA
CTD
PMID:26217789
NCBI chr 2:219,563,783...219,592,651
Ensembl chr 2:219,563,783...219,592,650
G
Ddb1
damage-specific DNA binding protein 1
affects binding
ISO
Thalidomide binds to [CRBN protein binds to DDB1 protein]
CTD
PMID:25108355
NCBI chr 1:226,657,561...226,683,356
Ensembl chr 1:226,657,561...226,683,347
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
Thalidomide analog results in increased expression of DDIT3 mRNA
CTD
PMID:20525221
NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
G
Defa10
defensin alpha 10
increases expression
ISO
Thalidomide results in increased expression of DEFA3 mRNA
CTD
PMID:26217789
NCBI chr16:75,498,236...75,499,012
Ensembl chr16:75,498,236...75,499,012
G
Defb15
defensin beta 15
increases expression
ISO
Thalidomide results in increased expression of DEFB15 mRNA
CTD
PMID:26217789
NCBI chr16:75,105,290...75,107,931
Ensembl chr16:75,105,290...75,107,931 Ensembl chr16:75,105,290...75,107,931
G
Des
desmin
multiple interactions
EXP
Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of DES protein]
CTD
PMID:17030452
NCBI chr 9:82,556,574...82,564,288
Ensembl chr 9:82,556,573...82,564,294
G
Dexi
Dexi homolog
increases expression
ISO
Thalidomide results in increased expression of DEXI mRNA
CTD
PMID:26217789
NCBI chr10:5,199,226...5,211,913
Ensembl chr10:5,199,226...5,211,913
G
Dlgap5
DLG associated protein 5
decreases expression
ISO
Thalidomide results in decreased expression of DLGAP5 mRNA
CTD
PMID:26217789
NCBI chr15:24,167,484...24,199,417
Ensembl chr15:24,167,486...24,199,341
G
Dlk1
delta like non-canonical Notch ligand 1
decreases expression
ISO
Thalidomide results in decreased expression of DLK1 mRNA
CTD
PMID:26217789
NCBI chr 6:133,576,513...133,583,751
Ensembl chr 6:133,552,821...133,583,751
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
increases expression
ISO
Thalidomide analog results in increased expression of DNAJB1 mRNA
CTD
PMID:20525221
NCBI chr19:24,747,178...24,750,919
Ensembl chr19:24,747,178...24,750,919
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
increases expression
ISO
Thalidomide analog results in increased expression of DNAJB4 mRNA
CTD
PMID:20525221
NCBI chr 2:257,394,692...257,425,344
Ensembl chr 2:257,394,818...257,425,242
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
increases expression
ISO
Thalidomide analog results in increased expression of DNAJB9 mRNA
CTD
PMID:20525221
NCBI chr 6:64,165,913...64,170,122
Ensembl chr 6:64,165,913...64,170,151
G
Dnajc19
DnaJ heat shock protein family (Hsp40) member C19
decreases expression
ISO
Thalidomide results in decreased expression of DNAJC19 mRNA
CTD
PMID:26217789
NCBI chr 2:120,503,093...120,531,782
Ensembl chr 2:120,504,130...120,531,782
G
Dus4l
dihydrouridine synthase 4-like
decreases expression
ISO
Thalidomide results in decreased expression of DUS4L mRNA
CTD
PMID:26217789
NCBI chr 6:50,925,987...50,943,546
Ensembl chr 6:50,928,397...50,943,488
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
Thalidomide analog results in increased expression of DUSP1 mRNA
CTD
PMID:20525221
NCBI chr10:16,970,642...16,973,425
Ensembl chr10:16,970,626...16,973,418
G
Dusp10
dual specificity phosphatase 10
increases expression
ISO
Thalidomide analog results in increased expression of DUSP10 mRNA
CTD
PMID:20525221
NCBI chr13:104,284,660...104,321,455
Ensembl chr13:104,284,660...104,321,455
G
Dusp8
dual specificity phosphatase 8
increases expression
ISO
Thalidomide analog results in increased expression of DUSP8 mRNA
CTD
PMID:20525221
NCBI chr 1:215,030,429...215,043,111
Ensembl chr 1:215,030,429...215,033,460
G
Eef1e1
eukaryotic translation elongation factor 1 epsilon 1
decreases expression
ISO
Thalidomide results in decreased expression of EEF1E1 mRNA
CTD
PMID:26217789
NCBI chr17:26,785,017...26,795,723
Ensembl chr17:26,785,029...26,797,161
G
Efcab2
EF-hand calcium binding domain 2
decreases expression
ISO
Thalidomide results in decreased expression of EFCAB2 mRNA
CTD
PMID:26217789
NCBI chr13:96,303,578...96,414,404
Ensembl chr13:96,303,703...96,414,404
G
Eif1b
eukaryotic translation initiation factor 1B
decreases expression
ISO
Thalidomide results in decreased expression of EIF1B mRNA
CTD
PMID:26217789
NCBI chr 8:129,158,112...129,160,726
Ensembl chr 8:129,158,103...129,160,757
G
Eif4e
eukaryotic translation initiation factor 4E
decreases expression
EXP
Thalidomide results in decreased expression of EIF4E protein
CTD
PMID:18291259
NCBI chr 2:243,819,616...243,853,987
Ensembl chr 2:243,820,661...243,852,631
G
Elane
elastase, neutrophil expressed
multiple interactions
ISO
Thalidomide inhibits the reaction [Lipopolysaccharides results in increased secretion of ELANE protein]; Thalidomide inhibits the reaction [lipoteichoic acid results in increased secretion of ELANE protein]
CTD
PMID:11302825
NCBI chr 7:12,638,320...12,640,168
Ensembl chr 7:12,638,322...12,640,232
G
Emc8
ER membrane protein complex subunit 8
decreases expression
ISO
Thalidomide results in decreased expression of EMC8 mRNA
CTD
PMID:26217789
NCBI chr19:54,235,949...54,245,810
Ensembl chr19:54,235,936...54,245,855
G
Erbb2
erb-b2 receptor tyrosine kinase 2
multiple interactions
ISO
[ERBB2 protein co-treated with PIK3CA protein mutant form] results in increased susceptibility to Thalidomide metabolite
CTD
PMID:28745489
NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
G
Esd
esterase D
decreases expression
ISO
Thalidomide results in decreased expression of ESD mRNA
CTD
PMID:26217789
NCBI chr15:56,756,848...56,776,348
Ensembl chr15:56,756,661...56,776,348
G
Eya1
EYA transcriptional coactivator and phosphatase 1
decreases expression
ISO
Thalidomide results in decreased expression of EYA1 mRNA
CTD
PMID:31711903
NCBI chr 5:4,275,728...4,495,525
Ensembl chr 5:4,373,626...4,513,142
G
F2r
coagulation factor II (thrombin) receptor
decreases expression
ISO
Thalidomide results in decreased expression of F2R mRNA; Thalidomide results in decreased expression of F2R protein
CTD
PMID:15618473
NCBI chr 2:26,118,760...26,135,340
Ensembl chr 2:26,118,760...26,135,340
G
Fabp5
fatty acid binding protein 5
decreases expression
ISO
Thalidomide results in decreased expression of FABP5 mRNA
CTD
PMID:26217789
NCBI chr 2:93,981,662...93,985,322
Ensembl chr 2:93,981,656...93,985,378
G
Fabp7
fatty acid binding protein 7
affects expression
ISO
Thalidomide affects the expression of FABP7 mRNA
CTD
PMID:26217789
NCBI chr20:40,769,624...40,773,156
Ensembl chr20:40,769,586...40,773,349
G
Fam174b
family with sequence similarity 174, member B
decreases expression
ISO
Thalidomide results in decreased expression of FAM174B mRNA
CTD
PMID:26217789
NCBI chr 1:135,081,596...135,180,266
Ensembl chr 1:135,083,974...135,162,685
G
Fas
Fas cell surface death receptor
decreases expression increases expression
ISO EXP
Thalidomide results in decreased expression of FAS protein Thalidomide results in increased expression of FAS mRNA
CTD
PMID:16531263 PMID:18291259
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
G
Faslg
Fas ligand
multiple interactions decreases expression
ISO
Thalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of FASL mRNA] Thalidomide results in decreased expression of FASLG protein
CTD
PMID:16510725 PMID:16531263
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
G
Fen1
flap structure-specific endonuclease 1
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of FEN1 mRNA
CTD
PMID:18720364
NCBI chr 1:226,251,516...226,256,160
Ensembl chr 1:226,251,518...226,255,886
G
Fgd3
FYVE, RhoGEF and PH domain containing 3
increases expression
ISO
Thalidomide results in increased expression of FGD3 mRNA
CTD
PMID:26217789
NCBI chr17:15,737,962...15,800,403
Ensembl chr17:15,749,978...15,800,401
G
Fgf2
fibroblast growth factor 2
increases response to substance decreases expression multiple interactions decreases activity affects secretion affects expression
ISO EXP
FGF2 protein results in increased susceptibility to Thalidomide Thalidomide results in decreased expression of FGF2 protein [temozolomide co-treated with Thalidomide] results in decreased expression of FGF2 protein Thalidomide results in decreased activity of FGF2 protein Thalidomide promotes the reaction [FGF2 protein results in decreased expression of MMP2 protein] Thalidomide affects the secretion of FGF2 protein Thalidomide affects the expression of FGF2 mRNA; Thalidomide affects the expression of FGF2 protein
CTD
PMID:11555579 PMID:12644816 PMID:14558594 PMID:15863203 PMID:15939924 PMID:16327979 PMID:17557286
NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
G
Fgf8
fibroblast growth factor 8
increases expression
ISO
Thalidomide results in increased expression of FGF8 mRNA
CTD
PMID:31711903
NCBI chr 1:265,492,949...265,498,965
Ensembl chr 1:265,493,124...265,498,831
G
Fgfr1
Fibroblast growth factor receptor 1
affects expression
ISO
Thalidomide affects the expression of FGFR1 mRNA
CTD
PMID:30834740
NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
G
Fgfr2
fibroblast growth factor receptor 2
decreases expression
ISO
Thalidomide results in decreased expression of FGFR2 mRNA; Thalidomide results in decreased expression of FGFR2 protein
CTD
PMID:30834740
NCBI chr 1:200,590,951...200,696,946
Ensembl chr 1:200,590,953...200,696,928
G
Fgfr3
fibroblast growth factor receptor 3
affects expression
ISO
Thalidomide affects the expression of FGFR3 mRNA
CTD
PMID:30834740
NCBI chr14:82,272,322...82,287,739
Ensembl chr14:82,273,070...82,287,706
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Thalidomide analog results in increased expression of FOS mRNA
CTD
PMID:20525221
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Thalidomide analog results in increased expression of FOSB mRNA
CTD
PMID:20525221
NCBI chr 1:80,214,691...80,221,417
Ensembl chr 1:80,214,494...80,221,710
G
Foxc2
forkhead box C2
decreases expression
ISO
Thalidomide results in decreased expression of FOXC2 mRNA
CTD
PMID:31711903
NCBI chr19:53,044,379...53,047,081
Ensembl chr19:53,044,379...53,047,081
G
Foxred1
FAD-dependent oxidoreductase domain containing 1
decreases expression
ISO
Thalidomide results in decreased expression of FOXRED1 mRNA
CTD
PMID:26217789
NCBI chr 8:36,401,317...36,410,589
Ensembl chr 8:36,403,493...36,410,612
G
Fzd8
frizzled class receptor 8
decreases expression
ISO
Thalidomide results in decreased expression of FZD8 mRNA
CTD
PMID:24154490
NCBI chr17:62,259,910...62,267,239
Ensembl chr17:62,262,129...62,265,113
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
multiple interactions
ISO
Thalidomide inhibits the reaction [lipopolysaccharide A results in increased expression of GADD45B mRNA]
CTD
PMID:15797874
NCBI chr 7:11,646,283...11,648,338
Ensembl chr 7:11,646,269...11,648,322
G
Galm
galactose mutarotase
decreases expression
ISO
Thalidomide results in decreased expression of GALM mRNA
CTD
PMID:26217789
NCBI chr 6:2,808,988...2,860,742
Ensembl chr 6:2,808,841...2,860,744
G
Gata3
GATA binding protein 3
increases expression
EXP
Thalidomide results in increased expression of GATA3 protein
CTD
PMID:19428696
NCBI chr17:72,419,752...72,452,043
Ensembl chr17:72,429,618...72,450,681
G
Gcnt2
glucosaminyl (N-acetyl) transferase 2 (I blood group)
decreases expression
ISO
Thalidomide results in decreased expression of GCNT2 mRNA
CTD
PMID:26217789
NCBI chr17:21,634,546...21,677,477
Ensembl chr17:21,634,551...21,739,408
G
Gemin2
gem (nuclear organelle) associated protein 2
decreases expression
ISO
Thalidomide results in decreased expression of GEMIN2 mRNA
CTD
PMID:26217789
NCBI chr 6:80,108,751...80,122,382
Ensembl chr 6:80,108,655...80,122,365
G
Gfra2
GDNF family receptor alpha 2
decreases expression
ISO
Thalidomide results in decreased expression of GFRA2 mRNA
CTD
PMID:26217789
NCBI chr15:52,557,004...52,648,984
Ensembl chr15:52,557,607...52,648,972
G
Got1
glutamic-oxaloacetic transaminase 1
increases expression
ISO
Thalidomide results in increased expression of GOT1 mRNA
CTD
PMID:26217789
NCBI chr 1:263,246,248...263,269,762
Ensembl chr 1:263,246,248...263,269,762
G
Gp2
glycoprotein 2
increases expression
ISO
Thalidomide results in increased expression of GP2 mRNA
CTD
PMID:26217789
NCBI chr 1:189,166,735...189,182,306
Ensembl chr 1:189,166,399...189,182,306
G
Gpatch4
G patch domain containing 4
decreases expression
ISO
Thalidomide results in decreased expression of GPATCH4 mRNA
CTD
PMID:26217789
NCBI chr 2:187,404,731...187,424,047
Ensembl chr 2:187,415,262...187,424,045
G
Gpx1
glutathione peroxidase 1
multiple interactions
EXP
Thalidomide inhibits the reaction [Carbon Tetrachloride results in decreased activity of GPX1 protein]
CTD
PMID:17030452
NCBI chr 8:117,117,430...117,118,528
Ensembl chr 8:117,117,430...117,118,522
G
Gpx8
glutathione peroxidase 8
decreases expression
ISO
Thalidomide results in decreased expression of GPX8 mRNA
CTD
PMID:26217789
NCBI chr 2:44,903,337...44,907,046
Ensembl chr 2:44,903,337...44,907,030
G
Gtf2e1
general transcription factor IIE subunit 1
decreases expression
ISO
Thalidomide results in decreased expression of GTF2E1 mRNA
CTD
PMID:26217789
NCBI chr11:66,078,786...66,111,394
Ensembl chr11:66,078,820...66,110,848
G
Gulp1
GULP PTB domain containing engulfment adaptor 1
decreases expression
ISO
Thalidomide results in decreased expression of GULP1 mRNA
CTD
PMID:26217789
NCBI chr 9:51,263,484...51,538,066
Ensembl chr 9:51,263,622...51,538,072
G
H2bc12
H2B clustered histone 12
decreases expression
ISO
Thalidomide results in decreased expression of H2BC12 mRNA
CTD
PMID:26217789
NCBI chr17:44,527,421...44,527,801
Ensembl chr17:44,527,421...44,527,801
G
H2bu1
H2B.U histone 1
decreases expression
ISO
Thalidomide results in decreased expression of H2BU2 mRNA
CTD
PMID:26217789
NCBI chr10:45,296,638...45,297,385
Ensembl chr10:45,296,638...45,297,385
G
H3c1
H3 clustered histone 1
decreases expression
ISO
Thalidomide results in decreased expression of H3C1 mRNA
CTD
PMID:26217789
NCBI chr17:43,616,206...43,616,735
Ensembl chr17:44,839,721...44,840,131 Ensembl chr17:44,839,721...44,840,131 Ensembl chr17:44,839,721...44,840,131 Ensembl chr17:44,839,721...44,840,131
G
H3f3c
H3 histone family member 3C
decreases expression
ISO
Thalidomide results in decreased expression of H3C15 mRNA
CTD
PMID:26217789
NCBI chr 7:94,777,659...94,778,656
Ensembl chr 7:94,777,702...94,778,696
G
Hcn1
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
decreases expression
ISO
Thalidomide results in decreased expression of HCN1 mRNA
CTD
PMID:26217789
NCBI chr 2:50,099,576...50,499,799
Ensembl chr 2:50,099,576...50,499,799
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
ISO
Thalidomide analog results in increased expression of HERPUD1 mRNA
CTD
PMID:20525221
NCBI chr19:11,046,905...11,057,440
Ensembl chr19:11,046,909...11,057,254
G
Hgf
hepatocyte growth factor
affects expression affects secretion decreases activity
ISO
Thalidomide affects the expression of HGF mRNA; Thalidomide affects the expression of HGF protein Thalidomide affects the secretion of HGF protein Thalidomide results in decreased activity of HGF protein
CTD
PMID:15939924 PMID:17557286
NCBI chr 4:15,435,460...15,505,377
Ensembl chr 4:15,433,295...15,505,362
G
Hirip3
HIRA interacting protein 3
decreases expression
ISO
Thalidomide results in decreased expression of HIRIP3 mRNA
CTD
PMID:26217789
NCBI chr 1:198,298,138...198,301,164
Ensembl chr 1:198,298,138...198,301,161
G
Hist1h2af
histone cluster 1 H2A family member F
decreases expression
ISO
Thalidomide results in decreased expression of H2AC15 mRNA
CTD
PMID:26217789
NCBI chr17:43,627,237...43,627,629
Ensembl chr17:43,627,237...43,627,629
G
Hist1h2bc
histone cluster 1, H2bc
decreases expression
ISO
Thalidomide results in decreased expression of H2BC4 mRNA
CTD
PMID:26217789
NCBI chr17:44,736,184...44,738,393
Ensembl chr17:44,737,950...44,738,330 Ensembl chr17:44,737,950...44,738,330
G
Hist2h4
histone cluster 2, H4
decreases expression
ISO
Thalidomide results in decreased expression of H4C11 mRNA
CTD
PMID:26217789
NCBI chr 2:198,411,955...198,412,350
Ensembl chr 2:198,411,955...198,412,350
G
Hmgn5
high mobility group nucleosome binding domain 5
decreases expression
ISO
Thalidomide results in decreased expression of HMGN5 mRNA
CTD
PMID:26217789
NCBI chr X:80,134,557...80,142,902
Ensembl chr X:80,134,557...80,142,902
G
Hoxb7
homeo box B7
increases expression
ISO
Thalidomide results in increased expression of HOXB7 mRNA
CTD
PMID:31711903
NCBI chr10:84,135,224...84,138,642
Ensembl chr10:84,135,116...84,138,637
G
Hoxb9
homeo box B9
increases expression
ISO
Thalidomide results in increased expression of HOXB9 mRNA
CTD
PMID:31711903
NCBI chr10:84,119,772...84,124,963
Ensembl chr10:84,119,884...84,123,390
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
decreases expression
ISO
Thalidomide results in decreased expression of HSD11B2 mRNA
CTD
PMID:26217789
NCBI chr19:37,476,083...37,481,326
Ensembl chr19:37,476,095...37,481,307
G
Hsf1
heat shock transcription factor 1
decreases expression
ISO
Thalidomide results in decreased expression of HSF1 mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr 7:117,538,523...117,565,478
Ensembl chr 7:117,538,523...117,565,478
G
Hspb1
heat shock protein family B (small) member 1
decreases expression
ISO
Thalidomide results in decreased expression of HSPB1 mRNA
CTD
PMID:26217789
NCBI chr12:23,839,390...23,841,051
Ensembl chr12:23,839,399...23,841,049
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
ISO
Thalidomide analog results in increased expression of HSPH1 mRNA
CTD
PMID:20525221
NCBI chr12:6,322,685...6,341,898
Ensembl chr12:6,322,668...6,341,902
G
Icam1
intercellular adhesion molecule 1
increases response to substance decreases expression
ISO EXP
ICAM1 gene SNP results in increased susceptibility to Thalidomide Thalidomide results in decreased expression of ICAM1 mRNA; Thalidomide results in decreased expression of ICAM1 protein
CTD
PMID:17174718 PMID:21245421
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
G
Idnk
Idnk, gluconokinase
decreases expression
ISO
Thalidomide results in decreased expression of IDNK mRNA
CTD
PMID:26217789
NCBI chr17:6,885,323...6,892,603
Ensembl chr17:6,885,221...6,892,497
G
Ifng
interferon gamma
multiple interactions decreases expression increases expression affects expression
ISO EXP
[Thalidomide co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG protein Thalidomide results in decreased expression of IFNG protein Thalidomide inhibits the reaction [irinotecan results in increased expression of IFNG protein]; Thalidomide promotes the reaction [irinotecan results in increased expression of IFNG protein] Thalidomide results in increased expression of IFNG; Thalidomide results in increased expression of IFNG protein Thalidomide affects the expression of IFNG mRNA
CTD
PMID:15588918 PMID:16078585 PMID:16454849 PMID:16514283 PMID:16815871 PMID:17089043
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
G
Ift27
intraflagellar transport 27
decreases expression
ISO
Thalidomide results in decreased expression of IFT27 mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr 7:119,393,384...119,409,710
Ensembl chr 7:119,393,384...119,409,710
G
Ift74
intraflagellar transport 74
decreases expression
ISO
Thalidomide results in decreased expression of IFT74 mRNA
CTD
PMID:26217789
NCBI chr 5:113,579,065...113,682,485
Ensembl chr 5:113,592,919...113,682,484
G
Igf1
insulin-like growth factor 1
affects expression
ISO
Thalidomide affects the expression of IGF1 mRNA
CTD
PMID:15939924
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
G
Igfbp3
insulin-like growth factor binding protein 3
affects expression decreases expression
ISO
Thalidomide affects the expression of IGFBP3 mRNA Thalidomide results in decreased expression of IGFBP3 mRNA
CTD
PMID:15939924 PMID:26217789
NCBI chr14:87,457,647...87,465,374
Ensembl chr14:87,457,647...87,465,374
G
Il10
interleukin 10
affects expression decreases expression
ISO
Thalidomide affects the expression of IL10 mRNA Thalidomide results in decreased expression of IL10 protein
CTD
PMID:16454849 PMID:16514283
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Il12a
interleukin 12A
multiple interactions
ISO
Thalidomide results in decreased expression of [IL12A protein binds to IL12B protein]
CTD
PMID:11788559
NCBI chr 2:165,076,945...165,083,996
Ensembl chr 2:165,076,607...165,084,318
G
Il12b
interleukin 12B
multiple interactions
ISO
Thalidomide results in decreased expression of [IL12A protein binds to IL12B protein] Thalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of IL12B mRNA]
CTD
PMID:11788559 PMID:16510725
NCBI chr10:30,034,447...30,048,774
Ensembl chr10:30,038,709...30,048,085
G
Il18
interleukin 18
increases expression
ISO
Thalidomide results in increased expression of IL18
CTD
PMID:17089043
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
G
Il1b
interleukin 1 beta
decreases expression multiple interactions
ISO EXP
Thalidomide results in decreased expression of IL1B protein Thalidomide inhibits the reaction [[Ethanol co-treated with Hydrochloric Acid] results in increased expression of IL1B protein]; Thalidomide inhibits the reaction [Paraquat results in increased expression of IL1B mRNA] Thalidomide inhibits the reaction [irinotecan results in increased expression of IL1B protein]; Thalidomide promotes the reaction [irinotecan results in increased expression of IL1B protein]
CTD
PMID:15863203 PMID:16815871 PMID:23510834 PMID:25478868
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Il1r1
interleukin 1 receptor type 1
decreases expression
ISO
Thalidomide results in decreased expression of IL1R1 mRNA
CTD
PMID:15618473
NCBI chr 9:46,962,291...47,038,139
Ensembl chr 9:46,962,288...47,036,670
G
Il1rn
interleukin 1 receptor antagonist
multiple interactions
ISO
Thalidomide promotes the reaction [SOD1 gene mutant form results in increased expression of IL1RN mRNA]
CTD
PMID:16510725
NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
G
Il2
interleukin 2
multiple interactions decreases expression
ISO EXP
[Thalidomide co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 protein Thalidomide inhibits the reaction [irinotecan results in decreased expression of IL2 protein]; Thalidomide promotes the reaction [irinotecan results in decreased expression of IL2 protein] Thalidomide results in decreased expression of IL2 protein
CTD
PMID:15588918 PMID:16815871
NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
G
Il4
interleukin 4
increases expression
EXP
Thalidomide results in increased expression of IL4 protein
CTD
PMID:16078585
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
G
Il6
interleukin 6
decreases secretion multiple interactions decreases activity
ISO EXP
Thalidomide analog results in decreased secretion of IL6 protein Thalidomide inhibits the reaction [[Ethanol co-treated with Hydrochloric Acid] results in increased expression of IL6 protein]; Thalidomide inhibits the reaction [Paraquat results in increased expression of IL6 mRNA] Thalidomide inhibits the reaction [irinotecan results in increased expression of IL6 protein]; Thalidomide inhibits the reaction [Paraquat results in increased expression of IL6 mRNA]; Thalidomide inhibits the reaction [Paraquat results in increased expression of IL6 protein] Thalidomide results in decreased activity of IL6 protein
CTD
PMID:15858615 PMID:16815871 PMID:17557286 PMID:23510834 PMID:25478868 PMID:26221080
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
G
Il6st
interleukin 6 signal transducer
decreases expression
ISO
Thalidomide results in decreased expression of IL6ST mRNA
CTD
PMID:15618473
NCBI chr 2:44,279,199...44,319,427
Ensembl chr 2:44,289,393...44,314,944
G
Ing3
inhibitor of growth family, member 3
increases expression
ISO
Thalidomide analog results in increased expression of ING3 mRNA
CTD
PMID:20525221
NCBI chr 4:49,017,235...49,044,450
Ensembl chr 4:49,017,311...49,042,990
G
Ipp
intracisternal A particle-promoted polypeptide
decreases expression
ISO
Thalidomide results in decreased expression of IPP mRNA
CTD
PMID:26217789
NCBI chr 5:135,351,767...135,390,363
Ensembl chr 5:135,351,816...135,388,083
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Thalidomide analog results in increased expression of JUN mRNA
CTD
PMID:20525221
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
G
Kdr
kinase insert domain receptor
multiple interactions
ISO
sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of KDR mRNA]
CTD
PMID:15741222
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
G
Kif2c
kinesin family member 2C
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of KIF2C mRNA
CTD
PMID:18720364
NCBI chr 5:136,027,923...136,053,268
Ensembl chr 5:136,027,934...136,053,210
G
Klhl4
kelch-like family member 4
decreases expression
ISO
Thalidomide results in decreased expression of KLHL4 mRNA
CTD
PMID:26217789
NCBI chr X:86,125,929...86,229,565
Ensembl chr X:86,126,157...86,229,563
G
Klk1
kallikrein 1
decreases expression
ISO
Thalidomide results in decreased expression of KLK1 mRNA
CTD
PMID:26217789
NCBI chr 1:100,131,562...100,135,556
Ensembl chr 1:100,059,967...100,203,329 Ensembl chr 1:100,059,967...100,203,329 Ensembl chr 1:100,059,967...100,203,329
G
Krtap1-1
keratin associated protein 1-1
increases expression
ISO
Thalidomide results in increased expression of KRTAP1-4 mRNA
CTD
PMID:26217789
NCBI chr10:87,502,950...87,503,578
Ensembl chr10:87,502,817...87,503,591
G
Lats2
large tumor suppressor kinase 2
increases expression
ISO
Thalidomide analog results in increased expression of LATS2 mRNA
CTD
PMID:20525221
NCBI chr15:37,943,609...37,995,175
Ensembl chr15:37,943,609...37,983,882
G
LOC100364500
RT1 class I, locus CE11-like
increases expression
ISO
Thalidomide results in increased expression of H2-Q1 mRNA
CTD
PMID:26217789
NCBI chr20:2,704,153...2,707,111
Ensembl chr20:2,704,148...2,707,120
G
LOC100910107
ubiquitin carboxyl-terminal hydrolase DUB-1-like
increases expression
ISO
Thalidomide results in increased expression of USP17LE mRNA
CTD
PMID:26217789
NCBI chr 1:169,720,247...169,721,788
Ensembl chr 1:169,720,253...169,721,758
G
LOC100910669
paired immunoglobulin-like type 2 receptor alpha-like
decreases expression
ISO
Thalidomide results in decreased expression of PILRA mRNA
CTD
PMID:26217789
NCBI chr12:21,678,550...21,689,821
Ensembl chr12:21,678,580...21,690,678
G
LOC100910887
olfactory receptor 6C4-like
decreases expression
ISO
Thalidomide results in decreased expression of OLFR820 mRNA
CTD
PMID:26217789
NCBI chr13:9,479,995...9,480,933
Ensembl chr13:9,479,995...9,480,933
G
LOC100912290
histone H4-like
decreases expression
ISO
Thalidomide results in decreased expression of H4C4 mRNA
CTD
PMID:26217789
NCBI chr 4:170,092,457...170,117,607
G
LOC100912489
histone H4-like
decreases expression
ISO
Thalidomide results in decreased expression of H4C3 mRNA
CTD
PMID:26217789
NCBI chr 4:170,144,871...170,145,311
Ensembl chr 4:170,144,951...170,145,262
G
LOC102553760
zinc finger protein 59-like
decreases expression
ISO
Thalidomide results in decreased expression of ZFP780B mRNA
CTD
PMID:26217789
NCBI chr 1:84,719,744...84,739,532
G
LOC103689988
2'-5'-oligoadenylate synthase 1A-like
decreases expression
ISO
Thalidomide results in decreased expression of OAS1G mRNA
CTD
PMID:26217789
NCBI chr12:42,367,110...42,376,531
Ensembl chr12:42,367,535...42,376,426
G
LOC103690022
protein N-terminal asparagine amidohydrolase
decreases expression
ISO
Thalidomide results in decreased expression of NTAN1 mRNA
CTD
PMID:26217789
NCBI chr10:3,218,408...3,235,229
Ensembl chr10:3,218,466...3,235,229
G
LOC501406
similar to regulator of sex-limitation candidate 1
decreases expression
ISO
Thalidomide results in decreased expression of ZFP273 mRNA
CTD
PMID:26217789
NCBI chr 1:38,581,867...38,597,702
Ensembl chr 1:38,582,629...38,586,563
G
LOC687082
similar to olfactory receptor 508
increases expression
ISO
Thalidomide results in increased expression of OLFR508 mRNA
CTD
PMID:26217789
NCBI chr 1:172,860,666...172,861,690
Ensembl chr 1:172,860,797...172,861,597
G
Lrr1
leucine rich repeat protein 1
decreases expression
ISO
Thalidomide results in decreased expression of LRR1 mRNA
CTD
PMID:26217789
NCBI chr 6:91,463,205...91,472,308
Ensembl chr 6:91,463,308...91,472,308
G
Ltf
lactotransferrin
multiple interactions
ISO
Thalidomide inhibits the reaction [Lipopolysaccharides results in increased secretion of LTF protein]; Thalidomide inhibits the reaction [lipoteichoic acid results in increased secretion of LTF protein]
CTD
PMID:11302825
NCBI chr 8:119,290,416...119,313,261
Ensembl chr 8:119,290,416...119,313,261
G
Ly96
lymphocyte antigen 96
decreases expression
ISO
Thalidomide results in decreased expression of LY96 mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr 5:1,972,212...1,989,448
G
Lyrm2
LYR motif containing 2
decreases expression
ISO
Thalidomide results in decreased expression of LYRM2 mRNA
CTD
PMID:26217789
NCBI chr 5:48,047,913...48,050,191
Ensembl chr 5:48,047,913...48,050,187
G
Lyrm4
LYR motif containing 4
decreases expression
ISO
Thalidomide results in decreased expression of LYRM4 mRNA
CTD
PMID:26217789
NCBI chr17:29,439,042...29,552,773
Ensembl chr17:29,438,980...29,552,790
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
multiple interactions
ISO
Thalidomide promotes the reaction [temozolomide results in increased expression of MAP1LC3B protein]
CTD
PMID:19567134
NCBI chr19:53,635,449...53,643,970
Ensembl chr19:53,629,779...53,646,058
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation
ISO
Thalidomide analog results in increased phosphorylation of MAPK1 protein
CTD
PMID:15858615
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk14
mitogen activated protein kinase 14
increases phosphorylation
ISO
Thalidomide analog results in increased phosphorylation of MAPK14 protein
CTD
PMID:15858615
NCBI chr20:5,933,290...5,995,137
Ensembl chr20:5,933,303...5,995,137
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation
ISO
Thalidomide analog results in increased phosphorylation of MAPK3 protein
CTD
PMID:15858615
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
decreases expression
ISO
Thalidomide analog results in decreased expression of MCL1 protein
CTD
PMID:15858615
NCBI chr 2:197,786,212...197,788,992
G
Mcm5
minichromosome maintenance complex component 5
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of MCM5 mRNA
CTD
PMID:18720364
NCBI chr19:14,523,482...14,561,281
Ensembl chr19:14,523,554...14,561,278
G
Meis2
Meis homeobox 2
multiple interactions
ISO
Thalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein]
CTD
PMID:25043012
NCBI chr 3:107,560,172...107,762,732
Ensembl chr 3:107,559,997...107,760,589
G
Meox1
mesenchyme homeobox 1
decreases expression
ISO
Thalidomide results in decreased expression of MEOX1 mRNA
CTD
PMID:31711903
NCBI chr10:89,797,011...89,817,009
Ensembl chr10:89,797,038...89,816,491
G
Mesp2
mesoderm posterior bHLH transcription factor 2
decreases expression
ISO
Thalidomide results in decreased expression of MESP2 mRNA
CTD
PMID:31711903
NCBI chr 1:141,550,633...141,553,239
Ensembl chr 1:141,550,633...141,553,230
G
Mettl5
methyltransferase like 5
decreases expression
ISO
Thalidomide results in decreased expression of METTL5 mRNA
CTD
PMID:26217789
NCBI chr 3:56,101,597...56,113,823
Ensembl chr 3:56,101,580...56,113,857
G
Mir301b
microRNA 301b
increases expression
ISO
Thalidomide results in increased expression of MIR301B mRNA
CTD
PMID:26217789
NCBI chr11:88,129,426...88,129,503
Ensembl chr11:88,129,426...88,129,503
G
Mir30e
microRNA 30e
decreases expression
ISO
Thalidomide results in decreased expression of MIR30E mRNA
CTD
PMID:26217789
NCBI chr 5:139,702,872...139,702,963
Ensembl chr 5:139,702,872...139,702,963
G
Mir449c
microRNA 449c
increases expression
ISO
Thalidomide results in increased expression of MIR449C mRNA
CTD
PMID:26217789
NCBI chr 2:44,896,066...44,896,164
Ensembl chr 2:44,896,066...44,896,164
G
Mixl1
Mix paired-like homeobox 1
decreases expression
ISO
Thalidomide results in decreased expression of MIXL1 mRNA
CTD
PMID:26217789
NCBI chr13:97,278,258...97,282,299
Ensembl chr13:98,973,041...98,975,426 Ensembl chr13:98,973,041...98,975,426
G
Mki67
marker of proliferation Ki-67
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of MKI67 mRNA
CTD
PMID:18720364
NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454
G
Mlf2
myeloid leukemia factor 2
decreases expression
ISO
Thalidomide results in decreased expression of MLF2 mRNA
CTD
PMID:26217789
NCBI chr 4:157,452,578...157,457,254
Ensembl chr 4:157,452,607...157,457,249
G
Mme
membrane metallo-endopeptidase
decreases expression
ISO
Thalidomide results in decreased expression of MME mRNA
CTD
PMID:26217789
NCBI chr 2:153,799,203...153,880,910
Ensembl chr 2:153,803,349...153,880,738
G
Mmp2
matrix metallopeptidase 2
multiple interactions decreases expression
ISO
Thalidomide promotes the reaction [FGF2 protein results in decreased expression of MMP2 protein] Thalidomide results in decreased expression of MMP2 protein
CTD
PMID:14558594 PMID:15863203
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Mmp9
matrix metallopeptidase 9
decreases expression
ISO
Thalidomide results in decreased expression of MMP9 protein
CTD
PMID:15863203
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
G
Moxd1
monooxygenase, DBH-like 1
decreases expression
ISO
Thalidomide results in decreased expression of MOXD1 mRNA
CTD
PMID:26217789
NCBI chr 1:22,124,498...22,206,565
Ensembl chr 1:22,124,495...22,206,505
G
Mpo
myeloperoxidase
multiple interactions
ISO
Thalidomide inhibits the reaction [[Ethanol co-treated with Hydrochloric Acid] results in increased activity of MPO protein]; Thalidomide inhibits the reaction [Indomethacin results in increased activity of MPO protein]
CTD
PMID:15138204 PMID:25478868
NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
G
Mpp1
membrane palmitoylated protein 1
decreases expression
ISO
Thalidomide results in decreased expression of MPP1 mRNA
CTD
PMID:26217789
NCBI chr 1:148,450,213...148,458,945
G
Mrpl32
mitochondrial ribosomal protein L32
decreases expression
ISO
Thalidomide results in decreased expression of MRPL32 mRNA
CTD
PMID:26217789
NCBI chr17:53,102,534...53,105,400
Ensembl chr17:53,102,534...53,105,400
G
Mrpl34
mitochondrial ribosomal protein L34
decreases expression
ISO
Thalidomide results in decreased expression of MRPL34 mRNA
CTD
PMID:26217789
NCBI chr16:19,874,034...19,874,769
Ensembl chr16:19,874,034...19,874,768
G
Mrpl47
mitochondrial ribosomal protein L47
decreases expression
ISO
Thalidomide results in decreased expression of MRPL47 mRNA
CTD
PMID:26217789
NCBI chr 2:119,128,311...119,139,451
Ensembl chr 2:119,128,309...119,139,451
G
Mrpl52
mitochondrial ribosomal protein L52
decreases expression
ISO
Thalidomide results in decreased expression of MRPL52 mRNA
CTD
PMID:26217789
NCBI chr15:33,069,479...33,072,777
Ensembl chr15:33,069,382...33,072,777
G
Mrps21
mitochondrial ribosomal protein S21
decreases expression
ISO
Thalidomide results in decreased expression of MRPS21 mRNA
CTD
PMID:26217789
NCBI chr 2:197,974,758...197,982,385
Ensembl chr 2:197,974,761...197,982,385
G
Mtfr2
mitochondrial fission regulator 2
decreases expression
ISO
Thalidomide results in decreased expression of MTFR2 mRNA
CTD
PMID:26217789
NCBI chr 1:15,834,779...15,850,424
Ensembl chr 1:15,782,477...15,860,624
G
Myb
MYB proto-oncogene, transcription factor
multiple interactions decreases phosphorylation decreases activity
ISO
CAT protein inhibits the reaction [Thalidomide results in decreased activity of MYB protein] Thalidomide results in decreased phosphorylation of MYB protein
CTD
PMID:16616857
NCBI chr 1:16,658,178...16,690,135
Ensembl chr 1:16,659,442...16,687,817
G
Mybpc3
myosin binding protein C3
decreases expression
ISO
Thalidomide results in decreased expression of MYBPC3 mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr 3:79,940,509...79,958,731
Ensembl chr 3:79,940,561...79,958,730
G
Myd88
MYD88, innate immune signal transduction adaptor
decreases expression
ISO
Thalidomide results in decreased expression of MYD88 mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr 8:128,022,512...128,027,462
Ensembl chr 8:128,022,473...128,026,841
G
Myh6
myosin heavy chain 6
affects expression
ISO
Thalidomide affects the expression of MYH6 mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr15:33,605,653...33,629,730
Ensembl chr15:33,605,654...33,629,699
G
Myl3
myosin light chain 3
affects expression decreases expression
ISO
Thalidomide affects the expression of MYL3 mRNA Thalidomide results in decreased expression of MYL3 mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr 8:119,030,852...119,036,996
Ensembl chr 8:119,030,875...119,036,996
G
Myl7
myosin light chain 7
decreases expression
ISO
Thalidomide results in decreased expression of MYL7 mRNA
CTD
PMID:26217789
NCBI chr14:86,144,770...86,147,075
Ensembl chr14:86,143,862...86,147,553
G
Mylk
myosin light chain kinase
increases expression
ISO
Thalidomide results in increased expression of MYLK mRNA
CTD
PMID:26217789
NCBI chr11:69,013,060...69,260,039
Ensembl chr11:69,013,050...69,223,158
G
Myom1
myomesin 1
decreases expression
ISO
Thalidomide results in decreased expression of MYOM1 mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr 9:119,353,840...119,469,196
Ensembl chr 9:119,353,840...119,468,715
G
Naa20
N(alpha)-acetyltransferase 20, NatB catalytic subunit
decreases expression
ISO
Thalidomide results in decreased expression of NAA20 mRNA
CTD
PMID:26217789
NCBI chr 3:140,106,723...140,125,047
Ensembl chr 3:140,106,766...140,125,220
G
Nanog
Nanog homeobox
decreases expression
ISO
Thalidomide results in decreased expression of NANOG mRNA
CTD
PMID:26217789
NCBI chr 4:155,531,906...155,539,268
Ensembl chr 4:155,531,906...155,539,268
G
Naxe
NAD(P)HX epimerase
decreases expression
ISO
Thalidomide results in decreased expression of NAXE mRNA
CTD
PMID:26217789
NCBI chr 2:187,424,319...187,426,410
Ensembl chr 2:187,424,327...187,426,375
G
Ndufb8
NADH:ubiquinone oxidoreductase subunit B8
decreases expression
ISO
Thalidomide results in decreased expression of NDUFB8 mRNA
CTD
PMID:26217789
NCBI chr 1:264,298,671...264,303,712
Ensembl chr 1:264,298,669...264,303,762
G
Nebl
nebulette
decreases expression
ISO
Thalidomide results in decreased expression of NEBL mRNA
CTD
PMID:26217789
NCBI chr17:84,141,014...84,247,038
Ensembl chr17:84,140,489...84,488,601
G
Neurod4
neuronal differentiation 4
increases expression
ISO
Thalidomide results in increased expression of NEUROD4 mRNA
CTD
PMID:26217789
NCBI chr 7:9,699,964...9,712,067
Ensembl chr 7:9,699,961...9,711,928
G
Neurog2
neurogenin 2
increases expression
ISO
Thalidomide results in increased expression of NEUROG2 mRNA
CTD
PMID:31711903
NCBI chr 2:231,962,517...231,963,441
Ensembl chr 2:231,962,517...231,963,308
G
Nfe2l2
nuclear factor, erythroid 2-like 2
multiple interactions
ISO
Thalidomide promotes the reaction [Paraquat results in increased expression of NFE2L2 mRNA]; Thalidomide promotes the reaction [Paraquat results in increased expression of NFE2L2 protein]
CTD
PMID:25579023
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions decreases expression
ISO EXP
[resveratrol co-treated with Thalidomide] results in decreased activity of [RELA protein binds to NFKB1 protein] Thalidomide results in decreased expression of NFKB1 protein
CTD
PMID:16333628 PMID:17164350
NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
G
Nfkbia
NFKB inhibitor alpha
multiple interactions increases expression
ISO EXP
Thalidomide inhibits the reaction [TGFB1 protein results in increased degradation of NFKBIA protein]; Thalidomide inhibits the reaction [TGFB1 protein results in increased phosphorylation of NFKBIA protein]; Thalidomide inhibits the reaction [TGFB1 protein results in increased transport of NFKBIA protein]; Thalidomide inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein] Thalidomide results in increased expression of NFKBIA protein Thalidomide inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFKBIA protein]; Thalidomide inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]
CTD
PMID:15687330 PMID:16288038 PMID:16604421 PMID:16943688 PMID:17174718
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
G
Nhlh1
nescient helix loop helix 1
increases expression
ISO
Thalidomide results in increased expression of NHLH1 mRNA
CTD
PMID:26217789
NCBI chr13:90,437,956...90,443,157
Ensembl chr13:90,437,956...90,443,157
G
NMS
neuromedin S
increases expression
ISO
Thalidomide results in increased expression of NMS mRNA
CTD
PMID:26217789
NCBI chr 9:45,605,552...45,616,912
Ensembl chr 9:45,605,552...45,616,912
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of NOS2 mRNA]
CTD
PMID:16604421
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
G
Nppb
natriuretic peptide B
multiple interactions
ISO
[Thalidomide co-treated with Dexamethasone] results in increased expression of NPPB protein
CTD
PMID:18414984
NCBI chr 5:164,796,176...164,797,538
Ensembl chr 5:164,796,185...164,797,531
G
Nqo2
N-ribosyldihydronicotinamide:quinone reductase 2
decreases expression
ISO
Thalidomide results in decreased expression of NQO2 mRNA
CTD
PMID:26217789
NCBI chr17:32,131,847...32,158,559
Ensembl chr17:32,132,347...32,158,538
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases expression
ISO
Thalidomide results in increased expression of NR1I2 mRNA
CTD
PMID:28496040
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
increases expression
ISO
Thalidomide analog results in increased expression of NR4A1 mRNA
CTD
PMID:20525221
NCBI chr 7:142,899,358...142,920,216
Ensembl chr 7:142,905,758...142,920,216
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
increases expression
ISO
Thalidomide analog results in increased expression of NR4A2 mRNA
CTD
PMID:20525221
NCBI chr 3:43,111,258...43,128,391
Ensembl chr 3:43,111,240...43,119,159
G
Nrp1
neuropilin 1
multiple interactions
ISO
sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP1 mRNA]
CTD
PMID:15741222
NCBI chr19:61,332,351...61,486,166
Ensembl chr19:61,332,351...61,485,858
G
Nrp2
neuropilin 2
multiple interactions
ISO
sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP2 mRNA]
CTD
PMID:15741222
NCBI chr 9:69,496,875...69,609,802
Ensembl chr 9:69,497,121...69,612,087
G
Nt5c3a
5'-nucleotidase, cytosolic IIIA
decreases expression
ISO
Thalidomide results in decreased expression of NT5C3 mRNA
CTD
PMID:26217789
NCBI chr 4:87,238,325...87,281,234
Ensembl chr 4:87,237,949...87,281,157
G
Nt5e
5' nucleotidase, ecto
decreases expression
ISO
Thalidomide results in decreased expression of NT5E mRNA
CTD
PMID:26217789
NCBI chr 8:95,969,002...96,012,733
Ensembl chr 8:95,968,652...96,012,696
G
Nudt14
nudix hydrolase 14
decreases expression
ISO
Thalidomide results in decreased expression of NUDT14 mRNA
CTD
PMID:26217789
NCBI chr 6:137,738,150...137,745,143
Ensembl chr 6:137,738,124...137,745,127
G
Nudt22
nudix hydrolase 22
decreases expression
ISO
Thalidomide results in decreased expression of NUDT22 mRNA
CTD
PMID:26217789
NCBI chr 1:222,247,500...222,251,053
Ensembl chr 1:222,247,502...222,250,980
G
Nup62cl
nucleoporin 62 C-terminal like
decreases expression
ISO
Thalidomide results in decreased expression of NUP62CL mRNA
CTD
PMID:26217789
NCBI chr X:111,333,274...111,390,023
Ensembl chr X:111,334,252...111,365,849
G
Nusap1
nucleolar and spindle associated protein 1
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of NUSAP1 mRNA
CTD
PMID:18720364
NCBI chr 3:111,422,267...111,452,600
Ensembl chr 3:111,422,267...111,452,971
G
Ocln
occludin
multiple interactions
ISO
Thalidomide inhibits the reaction [dinitrobenzenesulfonic acid results in decreased expression of OCLN protein]
CTD
PMID:16680017
NCBI chr 2:30,527,327...30,577,218
Ensembl chr 2:30,527,715...30,577,218
G
Olig2
oligodendrocyte transcription factor 2
increases expression
ISO
Thalidomide results in increased expression of OLIG2 mRNA
CTD
PMID:26217789
NCBI chr11:31,389,514...31,392,890
Ensembl chr11:31,389,514...31,392,890
G
Olig3
oligodendrocyte transcription factor 3
increases expression
ISO
Thalidomide results in increased expression of OLIG3 mRNA
CTD
PMID:31711903
NCBI chr 1:14,797,766...14,799,835
Ensembl chr 1:14,797,766...14,799,835
G
Olr1194
olfactory receptor 1194
decreases expression
ISO
Thalidomide results in decreased expression of OLFR160 mRNA
CTD
PMID:26217789
NCBI chr 8:40,191,902...40,192,831
Ensembl chr 8:40,191,902...40,192,831
G
Olr1235
olfactory receptor 1235
increases expression
ISO
Thalidomide results in increased expression of OLFR147 mRNA
CTD
PMID:26217789
NCBI chr 4:1,470,716...1,471,657
Ensembl chr 4:1,470,716...1,471,657
G
Olr137
olfactory receptor 137
increases expression
ISO
Thalidomide results in increased expression of OLFR635 mRNA
CTD
PMID:26217789
NCBI chr 1:169,153,297...169,154,262
Ensembl chr 1:169,153,297...169,154,262
G
Olr1394
olfactory receptor 1394
increases expression
ISO
Thalidomide results in increased expression of OLFR1385 mRNA
CTD
PMID:26217789
NCBI chr10:34,672,726...34,673,655
Ensembl chr10:34,672,726...34,673,655
G
Olr1519
olfactory receptor 1519
increases expression
ISO
Thalidomide results in increased expression of OLFR412 mRNA
CTD
PMID:26217789
NCBI chr10:61,160,125...61,161,060
Ensembl chr10:61,160,125...61,161,060 Ensembl chr10:61,160,125...61,161,060
G
Olr217
olfactory receptor 217
increases expression
ISO
Thalidomide results in increased expression of OLFR705 mRNA
CTD
PMID:26217789
NCBI chr 1:170,915,109...170,916,059
Ensembl chr 1:170,915,109...170,916,059
G
Olr374
olfactory receptor 374
increases expression
ISO
Thalidomide results in increased expression of OLFR1494 mRNA
CTD
PMID:26217789
NCBI chr 1:230,576,298...230,577,254
Ensembl chr 1:230,576,298...230,577,254
G
Olr588
olfactory receptor 588
increases expression
ISO
Thalidomide results in increased expression of OLFR152 mRNA
CTD
PMID:26217789
NCBI chr 3:75,936,795...75,937,739
Ensembl chr 3:75,936,795...75,937,739
G
Ostf1
osteoclast stimulating factor 1
decreases expression
ISO
Thalidomide results in decreased expression of OSTF1 mRNA
CTD
PMID:26217789
NCBI chr 1:234,749,568...234,796,739
Ensembl chr 1:234,749,568...234,796,739
G
Pabir1
PP2A Aalpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1
decreases expression
ISO
Thalidomide results in decreased expression of FAM122A mRNA
CTD
PMID:26217789
NCBI chr 1:242,372,458...242,373,764
Ensembl chr 1:242,372,458...242,373,764
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases cleavage
ISO
[Curcumin co-treated with Thalidomide] results in increased cleavage of PARP1 protein Thalidomide analog results in increased cleavage of PARP1 protein
CTD
PMID:15858615 PMID:19372569
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
G
Pax3
paired box 3
decreases expression
ISO
Thalidomide results in decreased expression of PAX3 mRNA
CTD
PMID:31711903
NCBI chr 9:84,004,004...84,101,226
Ensembl chr 9:84,005,183...84,101,172
G
Pax6
paired box 6
increases expression
ISO
Thalidomide results in increased expression of PAX6 mRNA
CTD
PMID:31711903
NCBI chr 3:95,700,241...95,728,682
Ensembl chr 3:95,707,386...95,728,624
G
Pdcd10
programmed cell death 10
decreases expression
ISO
Thalidomide results in decreased expression of PDCD10 mRNA
CTD
PMID:26217789
NCBI chr 2:173,966,701...174,012,730
Ensembl chr 2:173,967,080...174,012,676
G
Pdlim3
PDZ and LIM domain 3
decreases expression
ISO
Thalidomide results in decreased expression of PDLIM3 mRNA
CTD
PMID:26217789
NCBI chr16:49,543,140...49,574,362
Ensembl chr16:49,543,142...49,574,390
G
Pecam1
platelet and endothelial cell adhesion molecule 1
decreases expression
EXP
Thalidomide results in decreased expression of PECAM1 protein
CTD
PMID:18291259
NCBI chr10:94,850,971...94,913,202
G
Pfdn6
prefoldin subunit 6
decreases expression
ISO
Thalidomide results in decreased expression of PFDN6 mRNA
CTD
PMID:26217789
NCBI chr20:5,455,974...5,457,448
Ensembl chr20:5,455,974...5,457,444
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
multiple interactions
ISO
[ERBB2 protein co-treated with PIK3CA protein mutant form] results in increased susceptibility to Thalidomide metabolite
CTD
PMID:28745489
NCBI chr 2:118,831,350...118,861,456
Ensembl chr 2:118,831,350...118,861,454
G
Pilra
paired immunoglobin-like type 2 receptor alpha
decreases expression
ISO
Thalidomide results in decreased expression of PILRA mRNA
CTD
PMID:26217789
NCBI chr12:21,412,598...21,418,621
Ensembl chr12:21,412,538...21,420,169
G
Pim1
Pim-1 proto-oncogene, serine/threonine kinase
decreases expression
ISO
Thalidomide results in decreased expression of PIM1 protein
CTD
PMID:16616857
NCBI chr20:8,165,423...8,169,557
Ensembl chr20:8,165,307...8,169,555
G
Plau
plasminogen activator, urokinase
decreases expression
ISO
Thalidomide results in decreased expression of PLAU protein
CTD
PMID:16288038
NCBI chr15:3,644,296...3,650,765
Ensembl chr15:3,644,769...3,650,819
G
Plaur
plasminogen activator, urokinase receptor
multiple interactions decreases expression
ISO
Thalidomide inhibits the reaction [TGFB1 protein results in increased expression of PLAUR mRNA]; Thalidomide inhibits the reaction [TGFB1 protein results in increased expression of PLAUR protein] Thalidomide results in decreased expression of PLAUR protein
CTD
PMID:16288038
NCBI chr 1:81,328,171...81,344,954
Ensembl chr 1:81,328,183...81,344,708
G
Pltp
phospholipid transfer protein
decreases expression
ISO
Thalidomide results in decreased expression of PLTP mRNA
CTD
PMID:26217789
NCBI chr 3:161,304,469...161,322,289
Ensembl chr 3:161,304,469...161,322,289
G
Polr2k
RNA polymerase II, I and III subunit K
decreases expression
ISO
Thalidomide results in decreased expression of POLR2K mRNA
CTD
PMID:26217789
NCBI chr 7:74,939,010...74,992,594
Ensembl chr 7:74,989,223...74,992,582
G
Popdc2
popeye domain containing 2
decreases expression
ISO
Thalidomide results in decreased expression of POPDC2 mRNA
CTD
PMID:26217789
NCBI chr11:64,915,041...64,954,704
Ensembl chr11:64,936,692...64,952,687
G
Ppard
peroxisome proliferator-activated receptor delta
increases response to substance
ISO
PPARD gene SNP results in increased susceptibility to Thalidomide
CTD
PMID:21245421
NCBI chr20:7,818,289...7,883,482
Ensembl chr20:7,818,289...7,885,333
G
Ppp1r11
protein phosphatase 1, regulatory (inhibitor) subunit 11
decreases expression
ISO
Thalidomide results in decreased expression of PPP1R11 mRNA
CTD
PMID:26217789
NCBI chr20:2,094,931...2,098,438
Ensembl chr20:2,094,931...2,098,433
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression
ISO
Thalidomide analog results in increased expression of PPP1R15A mRNA
CTD
PMID:20525221
NCBI chr 1:101,511,899...101,515,043
Ensembl chr 1:101,511,901...101,514,974
G
Ppp1r1a
protein phosphatase 1, regulatory (inhibitor) subunit 1A
decreases expression
ISO
Thalidomide results in decreased expression of PPP1R1A mRNA
CTD
PMID:26217789
NCBI chr 7:145,146,480...145,154,131
Ensembl chr 7:145,146,481...145,154,131
G
Prelid2
PRELI domain containing 2
decreases expression
ISO
Thalidomide results in decreased expression of PRELID2 mRNA
CTD
PMID:26217789
NCBI chr18:36,198,522...36,286,217
Ensembl chr18:36,194,778...36,285,444
G
Prf1
perforin 1
increases expression
ISO
Thalidomide results in increased expression of PRF1
CTD
PMID:17089043
NCBI chr20:30,915,294...30,920,804
Ensembl chr20:30,915,213...30,921,382
G
Prkg1
protein kinase cGMP-dependent 1
decreases expression
ISO
Thalidomide results in decreased expression of PRKG1 mRNA
CTD
PMID:26217789
NCBI chr 1:248,982,039...250,300,952
G
Prr5
proline rich 5
decreases expression
ISO
Thalidomide results in decreased expression of PRR5 mRNA
CTD
PMID:26217789
NCBI chr 7:125,569,791...125,609,340
Ensembl chr 7:125,576,327...125,613,114
G
Prxl2a
peroxiredoxin like 2A
decreases expression
ISO
Thalidomide results in decreased expression of PRXL2A mRNA
CTD
PMID:26217789
NCBI chr16:17,494,000...17,513,781
Ensembl chr16:17,493,953...17,513,870
G
Psme2
proteasome activator subunit 2
increases expression
ISO
Thalidomide results in increased expression of PSME2 mRNA
CTD
PMID:26217789
NCBI chr15:34,265,552...34,269,851
Ensembl chr15:34,265,557...34,269,851
G
Pten
phosphatase and tensin homolog
increases expression
ISO
Thalidomide results in increased expression of PTEN protein
CTD
PMID:19567134
NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases degradation decreases stability multiple interactions decreases expression
ISO EXP
Thalidomide results in increased degradation of PTGS2 protein Thalidomide results in decreased stability of PTGS2 mRNA Thalidomide analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] Thalidomide inhibits the reaction [Ifosfamide results in increased expression of PTGS2 protein] Thalidomide results in decreased expression of PTGS2 protein
CTD
PMID:11705847 PMID:15982930 PMID:17638016
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
G
Rab2b
RAB2B, member RAS oncogene family
decreases expression
ISO
Thalidomide results in decreased expression of RAB2B mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr15:28,675,504...28,696,192
Ensembl chr15:28,677,055...28,696,122
G
Rab8a
RAB8A, member RAS oncogene family
decreases expression
ISO
Thalidomide results in decreased expression of RAB8A mRNA
CTD
PMID:26006729
NCBI chr16:19,355,047...19,376,776
Ensembl chr16:19,355,048...19,376,776
G
Rap1b
RAP1B, member of RAS oncogene family
decreases expression
ISO
Thalidomide results in decreased expression of RAP1B mRNA
CTD
PMID:26006729
NCBI chr 7:60,850,406...60,878,226
Ensembl chr 7:60,853,930...60,860,990
G
Rassf9
Ras association domain family member 9
decreases expression
ISO
Thalidomide results in decreased expression of RASSF9 mRNA
CTD
PMID:26217789
NCBI chr 7:44,146,345...44,178,179
Ensembl chr 7:44,146,237...44,181,201
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions decreases expression
ISO EXP
[irinotecan co-treated with Thalidomide co-treated with Celecoxib] results in increased expression of RELA protein; [irinotecan co-treated with Thalidomide] results in increased expression of RELA protein; [resveratrol co-treated with Thalidomide] results in decreased activity of [RELA protein binds to NFKB1 protein]; Thalidomide inhibits the reaction [TNF protein results in increased transport of RELA protein] Thalidomide analog inhibits the reaction [Lipopolysaccharides results in increased expression of RELA protein]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of RELA protein]; Thalidomide inhibits the reaction [Paraquat affects the localization of RELA protein] Thalidomide results in decreased expression of RELA protein [Thalidomide co-treated with Dimethylnitrosamine] results in decreased transport of RELA protein; Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of RELA mRNA]; Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of RELA protein]; Thalidomide inhibits the reaction [TNF protein results in increased expression of RELA mRNA]
CTD
PMID:15687330 PMID:16078585 PMID:16333628 PMID:16604421 PMID:16685529 PMID:16943688 PMID:17030452 PMID:17164350 PMID:17174718 PMID:23510834 PMID:26051520
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
G
Relb
RELB proto-oncogene, NF-kB subunit
increases expression
ISO
Thalidomide analog results in increased expression of RELB mRNA
CTD
PMID:20525221
NCBI chr 1:80,517,081...80,545,019
Ensembl chr 1:80,517,411...80,544,825
G
Rfc3
replication factor C subunit 3
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of RFC3 mRNA
CTD
PMID:18720364
NCBI chr12:1,460,581...1,471,344
Ensembl chr12:1,460,538...1,471,357
G
Rhoa
ras homolog family member A
affects expression
ISO
Thalidomide affects the expression of RHOA mRNA
CTD
PMID:26006729
NCBI chr 8:117,082,440...117,116,244
Ensembl chr 8:117,106,576...117,116,167
G
Rnaseh2c
ribonuclease H2, subunit C
decreases expression
ISO
Thalidomide results in decreased expression of RNASEH2C mRNA
CTD
PMID:26217789
NCBI chr 1:220,966,626...220,967,717
Ensembl chr 1:220,966,655...220,967,825
G
Rnf138
ring finger protein 138
decreases expression
ISO
Thalidomide results in decreased expression of RNF138 mRNA
CTD
PMID:26217789
NCBI chr18:15,146,925...15,167,361
G
Rnf166
ring finger protein 166
multiple interactions
ISO
Thalidomide results in increased degradation of and results in decreased expression of RNF166 protein
CTD
PMID:30067223
NCBI chr19:55,290,563...55,300,403
Ensembl chr19:55,290,563...55,300,403
G
Rps15
ribosomal protein S15
increases expression
ISO
Thalidomide results in increased expression of RPS15 mRNA
CTD
PMID:26217789
NCBI chr 7:12,282,134...12,283,573
Ensembl chr 7:12,282,109...12,283,608
G
Rps6ka2
ribosomal protein S6 kinase A2
decreases expression
ISO
Thalidomide results in decreased expression of RPS6KA2 mRNA
CTD
PMID:26217789
NCBI chr 1:53,219,346...53,499,445
Ensembl chr 1:53,360,157...53,499,445
G
Rras
RAS related
decreases expression
ISO
Thalidomide results in decreased expression of RRAS mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr 1:101,012,822...101,016,720
Ensembl chr 1:101,012,822...101,016,720
G
Rrm2
ribonucleotide reductase regulatory subunit M2
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of RRM2 mRNA
CTD
PMID:18720364
NCBI chr 6:43,884,627...43,890,818
Ensembl chr 6:43,884,678...43,889,515
G
RT1-S3
RT1 class Ib, locus S3
affects expression
ISO
Thalidomide affects the expression of HLA-E mRNA
CTD
PMID:25811541
NCBI chr20:3,176,124...3,180,825
Ensembl chr20:3,176,107...3,179,818
G
Rtn2
reticulon 2
decreases expression
ISO
Thalidomide results in decreased expression of RTN2 mRNA
CTD
PMID:26217789
NCBI chr 1:80,195,594...80,208,449
Ensembl chr 1:80,195,532...80,208,448
G
Ryr2
ryanodine receptor 2
decreases expression
ISO
Thalidomide results in decreased expression of RYR2 mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr17:65,533,998...65,955,606
Ensembl chr17:65,535,403...65,955,606
G
Sall4
spalt-like transcription factor 4
increases expression affects binding multiple interactions
ISO
Thalidomide results in increased expression of SALL4 mRNA Thalidomide binds to [SALL4 protein binds to CRBN protein] Bortezomib inhibits the reaction [Thalidomide results in increased degradation of and results in decreased expression of SALL4 protein]; MLN7243 inhibits the reaction [Thalidomide results in increased degradation of and results in decreased expression of SALL4 protein]; pevonedistat inhibits the reaction [Thalidomide results in increased degradation of and results in decreased expression of SALL4 protein]; Thalidomide results in increased degradation of and results in decreased expression of SALL4 protein
CTD
PMID:30067223
NCBI chr 3:165,520,155...165,538,176
Ensembl chr 3:165,520,392...165,537,940
G
Sap30
Sin3A associated protein 30
decreases expression
ISO
Thalidomide results in decreased expression of SAP30 mRNA
CTD
PMID:26217789
NCBI chr16:36,115,942...36,121,310
Ensembl chr16:36,116,258...36,121,097
G
Sat1
spermidine/spermine N1-acetyl transferase 1
decreases expression
ISO
Thalidomide results in decreased expression of SAT1 mRNA
CTD
PMID:26217789
NCBI chr X:43,626,480...43,629,767
Ensembl chr X:43,625,169...43,629,765
G
Scn7a
sodium voltage-gated channel alpha subunit 7
decreases expression
ISO
Thalidomide results in decreased expression of SCN7A mRNA
CTD
PMID:26217789
NCBI chr 3:52,775,779...52,877,365
Ensembl chr 3:52,777,214...52,849,907
G
Sdhaf1
succinate dehydrogenase complex assembly factor 1
decreases expression
ISO
Thalidomide results in decreased expression of SDHAF1 mRNA
CTD
PMID:26217789
NCBI chr 1:88,779,476...88,780,425
Ensembl chr 1:90,948,976...90,949,332
G
Sdhc
succinate dehydrogenase complex subunit C
decreases expression
ISO
Thalidomide results in decreased expression of SDHC mRNA
CTD
PMID:26217789
NCBI chr13:89,498,047...89,518,979
Ensembl chr13:89,498,048...89,518,939
G
Selenos
selenoprotein S
decreases expression
ISO
Thalidomide results in decreased expression of SELENOS mRNA
CTD
PMID:26006729
NCBI chr 1:126,979,579...126,989,344
Ensembl chr 1:126,979,575...126,989,344
G
Sell
selectin L
decreases expression
ISO
Thalidomide results in decreased expression of SELL protein
CTD
PMID:16344495
NCBI chr13:82,369,820...82,387,774
Ensembl chr13:82,369,493...82,387,631
G
Serpinb2
serpin family B member 2
increases response to substance
ISO
SERPINB2 gene SNP results in increased susceptibility to Thalidomide
CTD
PMID:21245421
NCBI chr13:27,449,907...27,463,015
Ensembl chr13:27,449,934...27,463,010
G
Sfrp2
secreted frizzled-related protein 2
increases expression
ISO
Thalidomide results in increased expression of SFRP2 mRNA
CTD
PMID:26217789
NCBI chr 2:182,723,732...182,731,277
Ensembl chr 2:182,723,854...182,731,764
G
Sh3bgr
SH3 domain binding glutamate-rich protein
decreases expression
ISO
Thalidomide results in decreased expression of SH3BGR mRNA
CTD
PMID:26217789
NCBI chr11:36,555,354...36,579,537
Ensembl chr11:36,555,416...36,579,535
G
Slc12a6
solute carrier family 12, member 6
increases response to substance
ISO
SLC12A6 gene SNP results in increased susceptibility to Thalidomide
CTD
PMID:21245421
NCBI chr 3:103,752,213...103,852,686
Ensembl chr 3:103,753,238...103,852,686
G
Slc13a4
solute carrier family 13 member 4
decreases expression
ISO
Thalidomide results in decreased expression of SLC13A4 mRNA
CTD
PMID:26217789
NCBI chr 4:62,796,732...62,841,053
Ensembl chr 4:62,797,677...62,840,357
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Thalidomide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,318,025...48,360,219
Ensembl chr 1:48,317,995...48,360,261
G
Slc25a20
solute carrier family 25 member 20
decreases expression
ISO
Thalidomide results in decreased expression of SLC25A20 mRNA
CTD
PMID:26217789
NCBI chr 8:117,455,308...117,476,762
Ensembl chr 8:117,455,262...117,476,734
G
Slc25a30
solute carrier family 25, member 30
decreases expression
ISO
Thalidomide results in decreased expression of SLC25A30 mRNA
CTD
PMID:26217789
NCBI chr15:57,811,612...57,834,173
Ensembl chr15:57,813,356...57,834,173
G
Slc2a3
solute carrier family 2 member 3
increases expression
ISO
Thalidomide results in increased expression of SLC2A3 mRNA
CTD
PMID:26217789
NCBI chr 4:155,549,991...155,626,018
Ensembl chr 4:155,408,233...155,631,856
G
Slc44a3
solute carrier family 44, member 3
decreases expression
ISO
Thalidomide results in decreased expression of SLC44A3 mRNA
CTD
PMID:26217789
NCBI chr 2:225,038,261...225,112,859
Ensembl chr 2:225,038,582...225,107,283
G
Slc8a1
solute carrier family 8 member A1
decreases expression
ISO
Thalidomide results in decreased expression of SLC8A1 mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr 6:4,244,076...4,564,262
Ensembl chr 6:4,258,991...4,520,604
G
Slco4c1
solute carrier organic anion transporter family, member 4C1
decreases expression
ISO
Thalidomide results in decreased expression of SLCO4C1 mRNA
CTD
PMID:26217789
NCBI chr 9:104,301,935...104,350,262
Ensembl chr 9:104,299,277...104,350,308
G
Smim4
small integral membrane protein 4
decreases expression
ISO
Thalidomide results in decreased expression of SMIM4 mRNA
CTD
PMID:26217789
NCBI chr16:7,206,632...7,210,518
G
Smpd2
sphingomyelin phosphodiesterase 2
multiple interactions
ISO
sphingosine 1-phosphate inhibits the reaction [Thalidomide results in increased activity of SMPD2 protein]
CTD
PMID:15741222
NCBI chr20:46,212,070...46,215,183
Ensembl chr20:46,211,892...46,215,120
G
Smyd1
SET and MYND domain containing 1
decreases expression
ISO
Thalidomide results in decreased expression of SMYD1 mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr 4:99,071,122...99,125,143
Ensembl chr 4:99,074,535...99,125,111
G
Snap25
synaptosome associated protein 25
increases expression
EXP
Thalidomide results in increased expression of SNAP25 mRNA; Thalidomide results in increased expression of SNAP25 protein
CTD
PMID:27693314
NCBI chr 3:129,697,408...129,788,417
Ensembl chr 3:129,599,353...129,788,400
G
Snrpd1
small nuclear ribonucleoprotein D1 polypeptide
decreases expression
ISO
Thalidomide results in decreased expression of SNRPD1 mRNA
CTD
PMID:26217789
NCBI chr18:1,866,066...1,876,613
Ensembl chr18:1,866,080...1,876,613
G
Snx16
sorting nexin 16
increases expression
ISO
Thalidomide analog results in increased expression of SNX16 mRNA
CTD
PMID:20525221
NCBI chr 2:93,518,796...93,541,056
Ensembl chr 2:93,518,806...93,540,328
G
Snx24
sorting nexin 24
decreases expression
ISO
Thalidomide results in decreased expression of SNX24 mRNA
CTD
PMID:26217789
NCBI chr18:48,201,653...48,355,701
Ensembl chr18:48,201,728...48,355,699
G
Sod1
superoxide dismutase 1
multiple interactions
ISO EXP
Thalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of FASL mRNA]; Thalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of IL12B mRNA]; Thalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of TNF mRNA]; Thalidomide promotes the reaction [SOD1 gene mutant form results in increased expression of IL1RN mRNA]; Thalidomide promotes the reaction [SOD1 gene mutant form results in increased expression of TGFB1 mRNA] Thalidomide inhibits the reaction [Carbon Tetrachloride results in decreased activity of SOD1 protein]
CTD
PMID:16510725 PMID:17030452
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
G
Sox1
SRY-box transcription factor 1
decreases expression
ISO
Thalidomide results in decreased expression of SOX1 mRNA
CTD
PMID:26217789
G
Sox17
SRY-box transcription factor 17
decreases localization
ISO
Thalidomide results in decreased localization of SOX17 protein
CTD
PMID:24154490
NCBI chr 5:14,890,318...14,895,907
Ensembl chr 5:14,890,408...14,895,907
G
Sp1
Sp1 transcription factor
decreases activity
ISO
Thalidomide results in decreased activity of SP1 protein
CTD
PMID:10533722
NCBI chr 7:144,014,173...144,044,635
Ensembl chr 7:144,014,173...144,044,629
G
Sp5
Sp5 transcription factor
decreases expression
ISO
Thalidomide results in decreased expression of SP5 mRNA
CTD
PMID:26217789
NCBI chr 3:56,766,475...56,769,277
Ensembl chr 3:56,766,475...56,769,277
G
Spa17
sperm autoantigenic protein 17
decreases expression
ISO
Thalidomide results in decreased expression of SPA17 mRNA
CTD
PMID:26217789
NCBI chr 8:40,066,954...40,078,131
Ensembl chr 8:40,067,076...40,078,165
G
Spag5
sperm associated antigen 5
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of SPAG5 mRNA
CTD
PMID:18720364
NCBI chr10:65,552,780...65,585,773
Ensembl chr10:65,566,171...65,585,760 Ensembl chr10:65,566,171...65,585,760
G
Sphkap
SPHK1 interactor, AKAP domain containing
decreases expression
ISO
Thalidomide results in decreased expression of SPHKAP mRNA
CTD
PMID:26217789
NCBI chr 9:89,050,405...89,195,435
Ensembl chr 9:89,050,381...89,195,273
G
Srrd
SRR1 domain containing
decreases expression
ISO
Thalidomide results in decreased expression of SRRD mRNA
CTD
PMID:26217789
NCBI chr12:50,315,876...50,321,488
Ensembl chr12:50,315,933...50,321,144
G
Stat3
signal transducer and activator of transcription 3
decreases phosphorylation multiple interactions
ISO
Thalidomide analog results in decreased phosphorylation of STAT3 protein [resveratrol co-treated with Thalidomide] results in decreased phosphorylation of STAT3 protein; Thalidomide promotes the reaction [Capsaicin results in decreased phosphorylation of and results in decreased activity of STAT3 protein]
CTD
PMID:15858615 PMID:17164350 PMID:17505005
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
G
Stmn2
stathmin 2
decreases expression
ISO
Thalidomide results in decreased expression of STMN2 mRNA
CTD
PMID:26217789
NCBI chr 2:95,424,251...95,471,900
Ensembl chr 2:95,424,251...95,472,115
G
Swsap1
SWIM-type zinc finger 7 associated protein 1
decreases expression
ISO
Thalidomide results in decreased expression of SWSAP1 mRNA
CTD
PMID:26217789
NCBI chr 8:22,966,752...22,969,280
Ensembl chr 8:22,966,561...22,969,459
G
Synj2bp
synaptojanin 2 binding protein
decreases expression
ISO
Thalidomide results in decreased expression of SYNJ2BP mRNA
CTD
PMID:26006729
NCBI chr 6:105,224,166...105,261,549
Ensembl chr 6:105,224,166...105,261,549
G
Tc2n
tandem C2 domains, nuclear
decreases expression
ISO
Thalidomide results in decreased expression of TC2N mRNA
CTD
PMID:26217789
NCBI chr 6:125,437,767...125,601,408
Ensembl chr 6:125,437,775...125,590,049
G
Tcf15
transcription factor 15
decreases expression
ISO
Thalidomide results in decreased expression of TCF15 mRNA
CTD
PMID:31711903
NCBI chr 3:147,643,250...147,649,511
Ensembl chr 3:147,643,250...147,649,504
G
Tdg
thymine-DNA glycosylase
decreases expression
ISO
Thalidomide results in decreased expression of TDG mRNA
CTD
PMID:26217789
NCBI chr 7:27,194,000...27,213,676
Ensembl chr 7:27,193,998...27,214,236
G
Tdgf1
teratocarcinoma-derived growth factor 1
decreases expression
ISO
Thalidomide results in decreased expression of TDGF1 mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr 8:119,215,266...119,220,909
Ensembl chr 8:119,215,495...119,219,232
G
Tefm
transcription elongation factor, mitochondrial
decreases expression
ISO
Thalidomide results in decreased expression of TEFM mRNA
CTD
PMID:26217789
NCBI chr10:67,476,006...67,478,830
Ensembl chr10:67,475,968...67,479,077
G
Tek
TEK receptor tyrosine kinase
decreases expression
ISO
Thalidomide results in decreased expression of TEK mRNA
CTD
PMID:15618473
NCBI chr 5:113,725,717...113,852,799
Ensembl chr 5:113,725,717...113,852,799
G
Tex16-ps1
testis expressed 16, pseudogene 1
decreases expression
ISO
Thalidomide results in decreased expression of TEX16 mRNA
CTD
PMID:26217789
G
Tgfb1
transforming growth factor, beta 1
multiple interactions decreases expression
ISO EXP
Thalidomide inhibits the reaction [TGFB1 protein results in increased degradation of NFKBIA protein]; Thalidomide inhibits the reaction [TGFB1 protein results in increased expression of PLAUR mRNA]; Thalidomide inhibits the reaction [TGFB1 protein results in increased expression of PLAUR protein]; Thalidomide inhibits the reaction [TGFB1 protein results in increased phosphorylation of NFKBIA protein]; Thalidomide inhibits the reaction [TGFB1 protein results in increased transport of NFKBIA protein] Thalidomide results in decreased expression of TGFB1 mRNA Thalidomide results in decreased expression of TGFB1 mRNA; Thalidomide results in decreased expression of TGFB1 protein Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA]; Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein]; Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of TGFB1 mRNA]; Thalidomide inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA]; Thalidomide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; Thalidomide inhibits the reaction [Thioacetamide results in increased expression of TGFB1 mRNA] Thalidomide promotes the reaction [SOD1 gene mutant form results in increased expression of TGFB1 mRNA]
CTD
PMID:15464241 PMID:16288038 PMID:16510725 PMID:16549389 PMID:16604421 PMID:17030452 PMID:18291259 PMID:26006729 PMID:26217789 PMID:26221080
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
G
Tgfbi
transforming growth factor, beta induced
decreases expression
ISO
Thalidomide results in decreased expression of TGFBI mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr17:8,400,123...8,429,338
Ensembl chr17:8,400,146...8,429,338
G
Tgfbr1
transforming growth factor, beta receptor 1
decreases expression
ISO
Thalidomide results in decreased expression of TGFBR1 mRNA; Thalidomide results in decreased expression of TGFBR1 protein
CTD
PMID:15618473
NCBI chr 5:63,056,071...63,119,635
Ensembl chr 5:63,050,758...63,119,635
G
Timp1
TIMP metallopeptidase inhibitor 1
multiple interactions
EXP
Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA]; Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 protein]; Thalidomide inhibits the reaction [Thioacetamide results in increased expression of TIMP1 mRNA]
CTD
PMID:15464241 PMID:17030452
NCBI chr X:1,364,771...1,369,451
Ensembl chr X:1,364,786...1,369,384
G
Timp2
TIMP metallopeptidase inhibitor 2
multiple interactions
EXP
Thalidomide inhibits the reaction [Thioacetamide results in increased expression of TIMP2 mRNA]
CTD
PMID:15464241
NCBI chr10:107,338,465...107,386,072
Ensembl chr10:107,338,465...107,386,072
G
Tinagl1
tubulointerstitial nephritis antigen-like 1
decreases expression
ISO
Thalidomide results in decreased expression of TINAGL1 mRNA
CTD
PMID:26217789
NCBI chr 5:148,382,702...148,392,729
Ensembl chr 5:148,382,706...148,392,697
G
Tjp1
tight junction protein 1
multiple interactions
ISO
Thalidomide inhibits the reaction [dinitrobenzenesulfonic acid results in decreased expression of TJP1 protein]
CTD
PMID:16680017
NCBI chr 1:126,146,489...126,515,359
Ensembl chr 1:126,146,489...126,227,469
G
Tm2d3
TM2 domain containing 3
decreases expression
ISO
Thalidomide results in decreased expression of TM2D3 mRNA
CTD
PMID:26217789
NCBI chr 1:126,573,474...126,595,778
Ensembl chr 1:126,586,543...126,595,603
G
Tmem138
transmembrane protein 138
decreases expression
ISO
Thalidomide results in decreased expression of TMEM138 mRNA
CTD
PMID:26217789
NCBI chr 1:226,623,861...226,630,911
Ensembl chr 1:226,623,861...226,630,900
G
Tmem176a
transmembrane protein 176A
decreases expression
ISO
Thalidomide results in decreased expression of TMEM176A mRNA
CTD
PMID:26217789
NCBI chr 4:78,458,735...78,462,415
Ensembl chr 4:78,458,625...78,462,423
G
Tmpo
thymopoietin
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of TMPO mRNA
CTD
PMID:18720364
NCBI chr 7:31,847,412...31,872,416
Ensembl chr 7:31,847,410...31,872,423
G
Tnf
tumor necrosis factor
multiple interactions decreases expression increases degradation increases expression
ISO EXP
Thalidomide analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Endotoxins results in increased expression of TNF protein]; Thalidomide inhibits the reaction [lipophosphonoglycan results in increased secretion of TNF protein]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; Thalidomide inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; Thalidomide inhibits the reaction [TNF protein results in increased expression of CXCL8 protein]; Thalidomide inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Thalidomide inhibits the reaction [TNF protein results in increased transport of RELA protein] Thalidomide results in decreased expression of TNF protein Thalidomide results in decreased expression of TNF mRNA; Thalidomide results in decreased expression of TNF protein Thalidomide results in increased degradation of TNF mRNA Thalidomide results in increased expression of TNF mRNA Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of TNF mRNA]; Thalidomide inhibits the reaction [irinotecan results in increased expression of TNF mRNA]; Thalidomide inhibits the reaction [irinotecan results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Paraquat results in increased expression of TNF mRNA]; Thalidomide inhibits the reaction [Paraquat results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Thioacetamide results in increased expression of TNF mRNA]; Thalidomide inhibits the reaction [TNF protein results in increased expression of CHUK protein]; Thalidomide inhibits the reaction [TNF protein results in increased expression of COL1A2 mRNA]; Thalidomide inhibits the reaction [TNF protein results in increased expression of RELA mRNA]; Thalidomide inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; Thalidomide inhibits the reaction [Zymosan results in increased expression of TNF protein] Thalidomide results in increased expression of TNF protein Thalidomide analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Thalidomide inhibits the reaction [[Ethanol co-treated with Hydrochloric Acid] results in increased expression of TNF protein]; Thalidomide inhibits the reaction [dinitrobenzenesulfonic acid results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Paraquat results in increased expression of TNF mRNA]; Thalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of TNF mRNA]; Thalidomide inhibits the reaction [Zymosan results in increased expression of TNF mRNA]; TNF protein affects the reaction [vadimezan affects the metabolism of Thalidomide]
CTD
PMID:9068814 PMID:9623511 PMID:10496904 PMID:10720640 PMID:11367517 PMID:11592764 PMID:11788559 PMID:12411981 PMID:12422154 PMID:14617101 PMID:14687169 PMID:15060740 PMID:15464241 PMID:15687330 PMID:15863203 PMID:15982930 PMID:16078585 PMID:16454849 PMID:16510725 PMID:16549389 PMID:16597438 PMID:16604421 PMID:16680017 PMID:16815871 PMID:16943688 PMID:18291259 PMID:19050852 PMID:23510834 PMID:25478868 PMID:26051520 PMID:26221080
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Tnfrsf10b
TNF receptor superfamily member 10b
decreases expression
ISO
Thalidomide results in decreased expression of TNFRSF10A protein
CTD
PMID:16531263
NCBI chr15:51,433,853...51,464,215
G
Tnfrsf1a
TNF receptor superfamily member 1A
decreases expression
ISO
Thalidomide results in decreased expression of TNFRSF1A mRNA; Thalidomide results in decreased expression of TNFRSF1A protein
CTD
PMID:15618473 PMID:16344495
NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633
G
Tnfrsf1b
TNF receptor superfamily member 1B
decreases expression
ISO
Thalidomide results in decreased expression of TNFRSF1B mRNA
CTD
PMID:15618473
NCBI chr 5:163,136,390...163,167,299
Ensembl chr 5:163,136,390...163,167,299
G
Tnfsf10
TNF superfamily member 10
decreases expression
ISO
Thalidomide results in decreased expression of TNFSF10 protein
CTD
PMID:16531263
NCBI chr 2:113,008,008...113,026,899
Ensembl chr 2:113,007,549...113,026,899
G
Tnfsf11
TNF superfamily member 11
multiple interactions
ISO
[Thalidomide co-treated with Dexamethasone] results in decreased expression of TNFSF11 protein
CTD
PMID:16079895
NCBI chr15:60,482,527...60,512,704
Ensembl chr15:60,482,527...60,512,704
G
Tnnc1
troponin C1, slow skeletal and cardiac type
decreases expression
ISO
Thalidomide results in decreased expression of TNNC1 mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr16:7,292,207...7,295,238
Ensembl chr16:7,292,096...7,295,465
G
Top2a
DNA topoisomerase II alpha
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of TOP2A mRNA
CTD
PMID:18720364
NCBI chr10:86,901,467...86,930,947
Ensembl chr10:86,901,007...86,932,154
G
Tp53
tumor protein p53
increases expression
ISO
Thalidomide analog results in increased expression of TP53 mRNA
CTD
PMID:20525221
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Tram1l1
translocation associated membrane protein 1-like 1
decreases expression
ISO
Thalidomide results in decreased expression of TRAM1L1 mRNA
CTD
PMID:26217789
NCBI chr 2:228,544,418...228,546,599
Ensembl chr 2:228,544,418...228,546,599
G
Trappc2l
trafficking protein particle complex 2-like
decreases expression
ISO
Thalidomide results in decreased expression of TRAPPC2L mRNA
CTD
PMID:26217789
NCBI chr19:55,423,350...55,428,551
Ensembl chr19:55,423,350...55,427,036
G
Trib3
tribbles pseudokinase 3
increases expression
ISO
Thalidomide analog results in increased expression of TRIB3 mRNA
CTD
PMID:20525221
NCBI chr 3:147,814,056...147,819,650
Ensembl chr 3:147,813,473...147,819,571
G
Trim55
tripartite motif-containing 55
decreases expression
ISO
Thalidomide results in decreased expression of TRIM55 mRNA
CTD
PMID:26217789
NCBI chr 2:104,416,972...104,459,117
Ensembl chr 2:104,416,972...104,459,107
G
Tspan33
tetraspanin 33
decreases expression
ISO
Thalidomide results in decreased expression of TSPAN33 mRNA
CTD
PMID:26217789
NCBI chr 4:56,981,283...57,005,866
Ensembl chr 4:56,981,283...57,004,792
G
Ttc30a1
tetratricopeptide repeat domain 30A1
decreases expression
ISO
Thalidomide results in decreased expression of TTC30A1 mRNA
CTD
PMID:26217789
NCBI chr 3:62,800,932...62,803,373
Ensembl chr 3:62,800,935...62,803,373
G
Ttc32
tetratricopeptide repeat domain 32
decreases expression
ISO
Thalidomide results in decreased expression of TTC32 mRNA
CTD
PMID:26217789
NCBI chr 6:34,154,973...34,161,857
Ensembl chr 6:34,155,017...34,161,171
G
Ttk
Ttk protein kinase
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of TTK mRNA
CTD
PMID:18720364
NCBI chr 8:91,368,065...91,405,995
Ensembl chr 8:91,368,111...91,405,993
G
Ttn
titin
decreases expression
ISO
Thalidomide results in decreased expression of TTN mRNA
CTD
PMID:26006729 PMID:26217789
NCBI chr 3:63,565,160...63,837,815
G
Ube2c
ubiquitin-conjugating enzyme E2C
multiple interactions
ISO
[Azacitidine co-treated with Thalidomide] affects the expression of UBE2C mRNA
CTD
PMID:18720364
NCBI chr 3:161,236,971...161,239,371
Ensembl chr 3:161,236,898...161,241,159
G
Ubxn1
UBX domain protein 1
decreases expression
ISO
Thalidomide results in decreased expression of UBXN1 mRNA
CTD
PMID:26217789
NCBI chr 1:225,067,953...225,071,944
Ensembl chr 1:225,068,009...225,071,945
G
Uchl3
ubiquitin C-terminal hydrolase L3
decreases expression
ISO
Thalidomide results in decreased expression of UCHL3 mRNA
CTD
PMID:26217789
NCBI chr15:86,153,624...86,198,127
Ensembl chr15:86,153,628...86,198,127
G
Uncx
UNC homeobox
decreases expression
ISO
Thalidomide results in decreased expression of UNCX mRNA
CTD
PMID:31711903
NCBI chr12:17,182,158...17,186,679
Ensembl chr12:17,182,163...17,186,679
G
Upp1
uridine phosphorylase 1
decreases expression
ISO
Thalidomide results in decreased expression of UPP1 mRNA
CTD
PMID:26217789
NCBI chr14:89,314,234...89,334,060
Ensembl chr14:89,314,176...89,334,276
G
Vcam1
vascular cell adhesion molecule 1
decreases expression
EXP
Thalidomide results in decreased expression of VCAM1 mRNA; Thalidomide results in decreased expression of VCAM1 protein
CTD
PMID:17174718
NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
G
Vegfa
vascular endothelial growth factor A
affects expression multiple interactions decreases expression increases expression decreases activity decreases secretion affects secretion
ISO EXP
Thalidomide affects the expression of VEGFA mRNA; Thalidomide affects the expression of VEGFA protein [Arsenic Trioxide co-treated with Thalidomide] results in decreased expression of VEGFA mRNA [temozolomide co-treated with Thalidomide] results in decreased expression of VEGFA protein Thalidomide results in decreased expression of VEGFA protein Thalidomide results in decreased expression of VEGFA mRNA [Thalidomide co-treated with Paclitaxel] results in decreased expression of VEGFA mRNA Thalidomide results in increased expression of VEGFA protein Thalidomide results in decreased expression of VEGFA mRNA; Thalidomide results in decreased expression of VEGFA protein Thalidomide results in decreased activity of VEGFA protein Thalidomide analog results in decreased secretion of VEGFA protein Thalidomide affects the secretion of VEGFA protein
CTD
PMID:15858615 PMID:15863203 PMID:15939924 PMID:15982930 PMID:16313753 PMID:16327979 PMID:17557286 PMID:18291259 PMID:21539454 PMID:24154490 PMID:29699374
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
G
Vegfb
vascular endothelial growth factor B
multiple interactions decreases expression
ISO
[Arsenic Trioxide co-treated with Thalidomide] results in decreased expression of VEGFB mRNA Thalidomide results in decreased expression of VEGFB mRNA
CTD
PMID:29699374
NCBI chr 1:222,237,000...222,242,786
Ensembl chr 1:222,239,022...222,242,644
G
Vegfc
vascular endothelial growth factor C
affects expression
ISO
Thalidomide affects the expression of VEGFC mRNA
CTD
PMID:29699374
NCBI chr16:40,440,371...40,555,178
Ensembl chr16:40,440,207...40,555,576
G
Vegfd
vascular endothelial growth factor D
multiple interactions decreases expression
ISO
[Arsenic Trioxide co-treated with Thalidomide] results in decreased expression of VEGFD mRNA Thalidomide results in decreased expression of VEGFD mRNA
CTD
PMID:29699374
NCBI chr X:31,816,480...31,852,239
Ensembl chr X:31,816,436...31,851,715
G
Vtn
vitronectin
decreases expression
ISO
Thalidomide results in decreased expression of VTN mRNA
CTD
PMID:26217789
NCBI chr10:65,767,960...65,771,040
Ensembl chr10:65,767,053...65,771,038
G
Wnt5b
Wnt family member 5B
decreases expression
ISO
Thalidomide results in decreased expression of WNT5B mRNA
CTD
PMID:24154490
NCBI chr 4:151,500,962...151,516,894
Ensembl chr 4:151,500,957...151,516,894
G
Wnt8a
Wnt family member 8A
decreases expression
ISO
Thalidomide results in decreased expression of WNT8A mRNA
CTD
PMID:26217789
NCBI chr18:27,331,236...27,336,829
Ensembl chr18:27,331,236...27,336,829
G
Xiap
X-linked inhibitor of apoptosis
decreases expression
ISO
Thalidomide analog results in decreased expression of XIAP protein
CTD
PMID:15858615
NCBI chr X:128,409,425...128,455,786
Ensembl chr X:128,409,472...128,453,000
G
Zcchc17
zinc finger CCHC-type containing 17
increases expression
ISO
Thalidomide results in increased expression of ZCCHC17 mRNA
CTD
PMID:26217789
NCBI chr 5:148,535,519...148,577,315
Ensembl chr 5:148,535,519...148,577,292
G
Zfp692
zinc finger protein 692
multiple interactions
ISO
Thalidomide results in increased degradation of and results in decreased expression of ZNF692 protein
CTD
PMID:30067223
NCBI chr10:43,740,739...43,752,713
Ensembl chr10:43,744,731...43,752,242
G
Zfpl1
zinc finger protein-like 1
decreases expression
ISO
Thalidomide results in decreased expression of ZFPL1 mRNA
CTD
PMID:26217789
NCBI chr 1:221,444,588...221,448,555
Ensembl chr 1:221,443,901...221,448,570
G
Zkscan5
zinc finger with KRAB and SCAN domains 5
decreases expression
ISO
Thalidomide results in decreased expression of ZKSCAN5 mRNA
CTD
PMID:26217789
NCBI chr12:11,154,807...11,176,002
Ensembl chr12:11,154,794...11,176,106
G
Zmat5
zinc finger, matrin type 5
decreases expression
ISO
Thalidomide results in decreased expression of ZMAT5 mRNA
CTD
PMID:26217789
NCBI chr14:84,937,843...84,968,898
Ensembl chr14:84,953,786...84,969,116
G
Znrd2
zinc ribbon domain containing 2
decreases expression
ISO
Thalidomide results in decreased expression of ZNRD2 mRNA
CTD
PMID:26217789
NCBI chr 1:221,087,803...221,089,586
Ensembl chr 1:221,087,803...221,089,586
G
Zscan12
zinc finger and SCAN domain containing 12
decreases expression
ISO
Thalidomide results in decreased expression of ZSCAN12 mRNA
CTD
PMID:26217789
NCBI chr17:45,279,171...45,285,069
Ensembl chr17:45,279,162...45,285,060
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all